%PDF-1.3
1 0 obj
<<
/Kids [ 4 0 R 5 0 R 6 0 R 7 0 R ]
/Type /Pages
/Count 4
>>
endobj
2 0 obj
<<
/Producer (Python PDF Library \055 http\072\057\057pybrary\056net\057pyPdf\057)
>>
endobj
3 0 obj
<<
/Type /Catalog
/Pages 1 0 R
>>
endobj
4 0 obj
<<
/Contents 8 0 R
/Parent 1 0 R
/Resources <<
/Font <<
/F2 9 0 R
/F3 10 0 R
/F1 11 0 R
>>
/ProcSet [ /Text /ImageC /ImageB /PDF /ImageI ]
>>
/Trans <<
>>
/Rotate 0
/MediaBox [ 0 0 595.27560 841.88980 ]
/Type /Page
>>
endobj
5 0 obj
<<
/Contents 12 0 R
/Parent 1 0 R
/Resources <<
/XObject <<
/FormXob.31b2a01266c0423b263008dda8a8282d 13 0 R
>>
/Font <<
/F2 9 0 R
/F3 10 0 R
/F1 11 0 R
>>
/ProcSet [ /Text /ImageC /ImageB /PDF /ImageI ]
>>
/Trans <<
>>
/Rotate 0
/MediaBox [ 0 0 595.27560 841.88980 ]
/Type /Page
>>
endobj
6 0 obj
<<
/Contents 14 0 R
/Parent 1 0 R
/Resources <<
/XObject <<
/FormXob.31b2a01266c0423b263008dda8a8282d 15 0 R
>>
/Font <<
/F2 16 0 R
/F3 17 0 R
/F1 18 0 R
>>
/ProcSet [ /Text /ImageC /ImageB /PDF /ImageI ]
>>
/Trans <<
>>
/Rotate 0
/MediaBox [ 0 0 595.27560 841.88980 ]
/Type /Page
>>
endobj
7 0 obj
<<
/Contents 19 0 R
/Parent 1 0 R
/Resources <<
/XObject <<
/FormXob.31b2a01266c0423b263008dda8a8282d 20 0 R
>>
/Font <<
/F2 21 0 R
/F3 22 0 R
/F1 23 0 R
/F4 24 0 R
>>
/ProcSet [ /Text /ImageC /ImageB /PDF /ImageI ]
>>
/Trans <<
>>
/Rotate 0
/MediaBox [ 0 0 595.27560 841.88980 ]
/Type /Page
>>
endobj
8 0 obj
<<
/Length 20351
>>
stream
q
1 0 0 1 0 0 cm
BT
/F1 12 Tf
14.40000 TL
ET
q
q
1 0 0 1 30 836.63980 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 2.62500 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
Q
Q
q
Q
Q
q
1 0 0 1 30 716.84190 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 0 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 0 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 17.52393 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Client) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 64.20000 17.52393 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(\072 ) Tj
/F2 9 Tf
(S\056R Medical Center) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 428 15.50000 cm
q
1 0 0 1 0 -1 cm
q
q
1 0 0 1 0 0 cm
q
[ ] 0 d
BT
/F3 10 Tf
12 TL
ET
1 w
0 0 0 RG
1 0 0 1 0 0 cm
0 j
BT
/F3 10 Tf
12 TL
ET
0 0 0 rg
0 J
q
1 0 0 1 0 7.54785 cm
q
1 0 0 1 0 0 cm
q
[ ] 0 d
0.00010 w
0 j
0 J
n
0 0 115 10 re
n
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
18 0 2 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
21 0 1 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
24 0 3 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
29 0 4 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
35 0 1 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
38 0 1 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
40 0 2 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
44 0 2 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
47 0 2 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
51 0 1 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
53 0 4 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
58 0 3 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
62 0 3 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
67 0 1 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
69 0 2 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
73 0 1 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
75 0 1 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
78 0 4 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
84 0 2 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
89 0 3 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
93 0 1 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
95 0 2 10 re
f*
Q
q
BT
/F1 7.79528 Tf
9.35433 TL
ET
BT
/F1 7.79528 Tf
9.35433 TL
ET
0 0 0 rg
BT
1 0 0 1 46.66457 -5.98880 Tm
(88019) Tj
T*
ET
Q
Q
Q
Q
Q
0.84375 w
BT
1 0 0 1 0 9.54785 Tm
19.79785 TL
115 0 Td
/F1 9 Tf
10.80000 TL
T*
-115 0 Td
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 0 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Patient Name) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 64.20000 0 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(\072 ) Tj
/F2 9 Tf
(Mr\056 J JAGADEESH) Tj
T*
ET
Q
Q
q
Q
Q
q
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 30 654.84190 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 0 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 0 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 46.50000 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Age\057Gender) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 64.20000 46.50000 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(\072 31 years \057 Male) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 31 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Phone) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 64.20000 31 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(\072) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 15.50000 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Ref\056 Dr\056) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 64.20000 15.50000 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(\072 SRI SATYA SAI LAB) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 0 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Req\056 No) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 64.20000 0 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F2 9 Tf
0 0 0 rg
(\072 2521055453) Tj
T*
ET
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 321 0 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 46.50000 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Sample Type) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 74.90000 46.50000 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(\072 Whole blood) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 31 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Registered On) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 74.90000 31 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(\072 20 May 2021 04\07215 PM) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 15.50000 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Collected On) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 74.90000 15.50000 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(\072 20 May 2021 04\07215 PM) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 0 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Reported On) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 74.90000 0 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(\072 20 May 2021 07\07210 PM) Tj
T*
ET
Q
Q
q
Q
Q
q
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 30 653.84190 cm
q
1 w
1 J
0 0 0 RG
n
0 0 m
535 0 l
S
Q
Q
q
1 0 0 1 30 632.26190 cm
q
1 0 0 1 1 -1 cm
q
0.91125 w
BT
1 0 0 1 0 9.60104 Tm
240.57190 0 Td
14.58000 TL
/F1 9.72000 Tf
0 0 0 rg
(Hematology) Tj
T*
-240.57190 0 Td
ET
Q
Q
q
Q
Q
q
1 0 0 1 30 613.64340 cm
q
1 0 0 1 1 -1 cm
q
1.03866 w
BT
1 0 0 1 0 10.66378 Tm
186.78660 0 Td
16.61850 TL
/F2 11.07900 Tf
0 0 0 rg
(Complete Blood Picture \050CBP\051) Tj
T*
-186.78660 0 Td
ET
Q
Q
q
Q
Q
q
1 0 0 1 30 596.14340 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 0 cm
q
1 0 0 1 0 -2 cm
q
0.84375 w
BT
1 0 0 1 0 9.03800 Tm
70.86850 0 Td
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Test Name) Tj
T*
-70.86850 0 Td
ET
Q
Q
q
Q
Q
q
1 0 0 1 187.25000 0 cm
q
1 0 0 1 0 -2 cm
q
0.84375 w
BT
1 0 0 1 0 9.03800 Tm
16.98250 0 Td
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Observed Values) Tj
T*
-16.98250 0 Td
ET
Q
Q
q
Q
Q
q
1 0 0 1 294.25000 0 cm
q
1 0 0 1 0 -2 cm
q
0.84375 w
BT
1 0 0 1 0 9.03800 Tm
28.87500 0 Td
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Units) Tj
T*
-28.87500 0 Td
ET
Q
Q
q
Q
Q
q
1 0 0 1 374.50000 0 cm
q
1 0 0 1 0 -2 cm
q
0.84375 w
BT
1 0 0 1 0 9.03800 Tm
15.97650 0 Td
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Biological Reference Intervals) Tj
T*
-15.97650 0 Td
ET
Q
Q
q
Q
Q
q
2 J
1 j
0 0 0 RG
0.80000 w
n
0 17.50000 m
535 17.50000 l
S
n
0 0 m
0 17.50000 l
S
n
535 0 m
535 17.50000 l
S
n
0 0 m
535 0 l
S
n
0 17.50000 m
535 17.50000 l
S
n
0 0 m
0 17.50000 l
S
n
535 0 m
535 17.50000 l
S
n
0 0 m
535 0 l
S
n
0 17.50000 m
187.25000 17.50000 l
S
n
0 0 m
0 17.50000 l
S
n
187.25000 0 m
187.25000 17.50000 l
S
n
0 0 m
187.25000 0 l
S
n
187.25000 17.50000 m
294.25000 17.50000 l
S
n
187.25000 0 m
187.25000 17.50000 l
S
n
294.25000 0 m
294.25000 17.50000 l
S
n
187.25000 0 m
294.25000 0 l
S
n
294.25000 17.50000 m
374.50000 17.50000 l
S
n
294.25000 0 m
294.25000 17.50000 l
S
n
374.50000 0 m
374.50000 17.50000 l
S
n
294.25000 0 m
374.50000 0 l
S
n
374.50000 17.50000 m
535 17.50000 l
S
n
374.50000 0 m
374.50000 17.50000 l
S
n
535 0 m
535 17.50000 l
S
n
374.50000 0 m
535 0 l
S
Q
Q
Q
q
1 0 0 1 30 552.88980 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 10.50000 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 5 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Hemoglobin) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 -0 cm
q
1 0 0 1 0 0 cm
q
0.65625 w
BT
1 0 0 1 5 5.47400 Tm
10.50000 TL
/F1 7 Tf
0 0 0 rg
(\050Method \072 Colorimetry\051) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 187.25000 10.50000 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 20 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(15\0568) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 294.25000 10.50000 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 5 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(g\057dL) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 376.50000 10.50000 cm
q
1 0 0 1 2 0 cm
q
0.84375 w
BT
1 0 0 1 5 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(13 \055 17) Tj
T*
ET
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 30 528.88980 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 10.50000 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 5 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(PCV\057HCT) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 -0 cm
q
1 0 0 1 0 0 cm
q
0.65625 w
BT
1 0 0 1 5 5.47400 Tm
10.50000 TL
/F1 7 Tf
0 0 0 rg
(\050Method \072 Calculated\051) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 187.25000 10.50000 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 20 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(47\0565) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 294.25000 10.50000 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 5 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(\045) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 376.50000 10.50000 cm
q
1 0 0 1 2 0 cm
q
0.84375 w
BT
1 0 0 1 5 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(40\0560 \055 50\0560) Tj
T*
ET
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 30 504.88980 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 10.50000 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 5 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Total RBC count) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 -0 cm
q
1 0 0 1 0 0 cm
q
0.65625 w
BT
1 0 0 1 5 5.47400 Tm
10.50000 TL
/F1 7 Tf
0 0 0 rg
(\050Method \072 Electrical Impedance\051) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 187.25000 10.50000 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 20 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(5\05625) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 294.25000 10.50000 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 5 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(mil\057cumm) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 376.50000 10.50000 cm
q
1 0 0 1 2 0 cm
q
0.84375 w
BT
1 0 0 1 5 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(4\0564 \055 5\0565) Tj
T*
ET
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 30 480.88980 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 10.50000 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 5 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Total WBC Count) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 -0 cm
q
1 0 0 1 0 0 cm
q
0.65625 w
BT
1 0 0 1 5 5.47400 Tm
10.50000 TL
/F1 7 Tf
0 0 0 rg
(\050Method \072 Electrical Impedance\051) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 187.25000 10.50000 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 20 7.03800 Tm
13.50000 TL
/F2 9 Tf
0 0 0 rg
(11120) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 294.25000 10.50000 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 5 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(cells\057cumm) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 376.50000 10.50000 cm
q
1 0 0 1 2 0 cm
q
0.84375 w
BT
1 0 0 1 5 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(4000 \055 11000) Tj
T*
ET
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 30 456.88980 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 10.50000 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 5 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Platelet Count) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 -0 cm
q
1 0 0 1 0 0 cm
q
0.65625 w
BT
1 0 0 1 5 5.47400 Tm
10.50000 TL
/F1 7 Tf
0 0 0 rg
(\050Method \072 Elcetrical Impedence\051) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 187.25000 10.50000 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 20 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(2\05691) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 294.25000 10.50000 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 5 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(lakhs\057cumm) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 376.50000 10.50000 cm
q
1 0 0 1 2 0 cm
q
0.84375 w
BT
1 0 0 1 5 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(1\0565 \055 4\0561) Tj
T*
ET
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 30 443.38980 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 -0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 5 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(PDW) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 187.25000 -0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 20 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(9\0568) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 294.25000 -0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 5 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(fL) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 376.50000 -0 cm
q
1 0 0 1 2 0 cm
q
0.84375 w
BT
1 0 0 1 5 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(\055) Tj
T*
ET
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 30 429.88980 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 -0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 5 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(MCV) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 187.25000 -0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 20 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(90\0565) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 294.25000 -0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 5 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(fL) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 376.50000 -0 cm
q
1 0 0 1 2 0 cm
q
0.84375 w
BT
1 0 0 1 5 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(83 \055 101) Tj
T*
ET
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 30 416.38980 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 -0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 5 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(MCH) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 187.25000 -0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 20 7.03800 Tm
13.50000 TL
/F2 9 Tf
0 0 0 rg
(32\0567) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 294.25000 -0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 5 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(pg) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 376.50000 -0 cm
q
1 0 0 1 2 0 cm
q
0.84375 w
BT
1 0 0 1 5 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(27 \055 32) Tj
T*
ET
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 30 402.88980 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 -0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 5 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(MCHC) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 187.25000 -0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 20 7.03800 Tm
13.50000 TL
/F2 9 Tf
0 0 0 rg
(35\0561) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 294.25000 -0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 5 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(g\057dL) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 376.50000 -0 cm
q
1 0 0 1 2 0 cm
q
0.84375 w
BT
1 0 0 1 5 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(31\0565 \055 34\0565) Tj
T*
ET
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 30 385.38980 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 -0 cm
q
1 0 0 1 0 -2 cm
q
0.84375 w
BT
1 0 0 1 5 9.03800 Tm
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Differential Count) Tj
T*
ET
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 30 371.88980 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 -0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 5 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Neutrophils) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 187.25000 -0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 20 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(76) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 294.25000 -0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 5 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(\045) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 376.50000 -0 cm
q
1 0 0 1 2 0 cm
q
0.84375 w
BT
1 0 0 1 5 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(40 \055 80) Tj
T*
ET
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 30 358.38980 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 -0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 5 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Lymphocytes) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 187.25000 -0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 20 7.03800 Tm
13.50000 TL
/F2 9 Tf
0 0 0 rg
(16) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 294.25000 -0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 5 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(\045) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 376.50000 -0 cm
q
1 0 0 1 2 0 cm
q
0.84375 w
BT
1 0 0 1 5 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(20 \055 40) Tj
T*
ET
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 30 344.88980 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 -0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 5 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Eosinophils) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 187.25000 -0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 20 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(04) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 294.25000 -0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 5 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(\045) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 376.50000 -0 cm
q
1 0 0 1 2 0 cm
q
0.84375 w
BT
1 0 0 1 5 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(1 \055 6) Tj
T*
ET
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 30 331.38980 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 -0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 5 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Monocytes) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 187.25000 -0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 20 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(04) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 294.25000 -0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 5 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(\045) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 376.50000 -0 cm
q
1 0 0 1 2 0 cm
q
0.84375 w
BT
1 0 0 1 5 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(2 \055 10) Tj
T*
ET
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 30 307.38980 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 10.50000 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 5 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Basophils) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 -0 cm
q
1 0 0 1 0 0 cm
q
0.65625 w
BT
1 0 0 1 5 5.47400 Tm
10.50000 TL
/F1 7 Tf
0 0 0 rg
(\050Method \072 VCS\057MICROSCOPY\051) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 187.25000 10.50000 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 20 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(00) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 294.25000 10.50000 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 5 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(\045) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 376.50000 10.50000 cm
q
1 0 0 1 2 0 cm
q
0.84375 w
BT
1 0 0 1 5 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(0 \055 2) Tj
T*
ET
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 30 289.88980 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 -0 cm
q
1 0 0 1 0 -2 cm
q
0.84375 w
BT
1 0 0 1 5 9.03800 Tm
13.50000 TL
/F2 9 Tf
0 0 0 rg
(PERIPHERAL BLOOD PICTURE) Tj
T*
ET
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 30 276.38980 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 -0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 5 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(RBC) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 187.25000 -0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 20 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Normocytic normochromic RBCs are seen\056) Tj
T*
ET
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 30 262.88980 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 -0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 5 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(WBC) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 187.25000 -0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 20 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Absolute neutrophilic leucocytosis\056) Tj
T*
ET
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 30 249.38980 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 -0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 5 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Platelets) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 187.25000 -0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 20 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Adequate and seen discretely\056) Tj
T*
ET
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 30 235.88980 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 -0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 5 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Hemoparasites) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 187.25000 -0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 20 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(No hemoparasites seen\056) Tj
T*
ET
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 30 222.38980 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 -0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 5 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Impression\072) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 187.25000 -0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 20 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Normocytic normochromic blood picture with absolute neutrophilia\056) Tj
T*
ET
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 30 204.88980 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 -0 cm
q
1 0 0 1 0 -2 cm
q
0.84375 w
BT
1 0 0 1 5 9.03800 Tm
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Method\072 Microscopy\054Fully Automated Hematology Analyser) Tj
T*
ET
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 30 119.88980 cm
q
1 0 0 1 2 -2 cm
q
0.84375 w
0.84375 w
0.84375 w
0.84375 w
0.84375 w
0.84375 w
BT
1 0 0 1 0 78.53800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
( ) Tj
T*
/F2 9 Tf
(Reference \072) Tj
/F1 9 Tf
T*
(Dacie and Lewis Practical Hematology\05410th Edition) Tj
T*
(Note \072 These results are generated by a fully automated hematology analyzer and the differential count is computed from a total of) Tj
T*
(several thousands of cells\056 Therefore the differential count appears in decimalised numbers and may not add upto exactly 100\056 It may) Tj
T*
(fall between 99 and 101\056) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 30 104.38980 cm
q
1 0 0 1 1 -1 cm
q
0.84375 w
BT
1 0 0 1 0 9.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 30 78.88979 cm
q
1 0 0 1 1 -11 cm
q
0.84375 w
BT
1 0 0 1 0 19.03800 Tm
231.73300 0 Td
13.50000 TL
/F1 9 Tf
0 0 0 rg
(\052\052End of Report\052\052) Tj
T*
-231.73300 0 Td
ET
Q
Q
q
Q
Q
Q
q
1 0 0 1 0 0 cm
BT
/F1 12 Tf
14.40000 TL
ET
BT
/F1 9 Tf
14.40000 TL
ET
BT
1 0 0 1 519 13 Tm
(Page 1 of 4) Tj
T*
ET
Q

endstream
endobj
9 0 obj
<<
/Encoding /WinAnsiEncoding
/Type /Font
/Name /F2
/BaseFont /Helvetica-Bold
/Subtype /Type1
>>
endobj
10 0 obj
<<
/Encoding /WinAnsiEncoding
/Type /Font
/Name /F3
/BaseFont /Times-Roman
/Subtype /Type1
>>
endobj
11 0 obj
<<
/Encoding /WinAnsiEncoding
/Type /Font
/Name /F1
/BaseFont /Helvetica
/Subtype /Type1
>>
endobj
12 0 obj
<<
/Length 7529
>>
stream
q
1 0 0 1 0 0 cm
BT
/F1 12 Tf
14.40000 TL
ET
q
q
1 0 0 1 30 836.63980 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 2.62500 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
Q
Q
q
Q
Q
q
1 0 0 1 30 716.84190 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 0 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 0 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 17.52393 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Client) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 64.20000 17.52393 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(\072 ) Tj
/F2 9 Tf
(S\056R Medical Center) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 428 15.50000 cm
q
1 0 0 1 0 -1 cm
q
q
1 0 0 1 0 0 cm
q
[ ] 0 d
BT
/F3 10 Tf
12 TL
ET
1 w
0 0 0 RG
1 0 0 1 0 0 cm
0 j
BT
/F3 10 Tf
12 TL
ET
0 0 0 rg
0 J
q
1 0 0 1 0 7.54785 cm
q
1 0 0 1 0 0 cm
q
[ ] 0 d
0.00010 w
0 j
0 J
n
0 0 115 10 re
n
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
18 0 2 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
21 0 1 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
24 0 3 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
29 0 4 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
35 0 1 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
38 0 1 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
40 0 2 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
44 0 2 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
47 0 2 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
51 0 1 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
53 0 4 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
58 0 3 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
62 0 3 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
67 0 1 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
69 0 2 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
73 0 1 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
75 0 1 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
78 0 4 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
84 0 2 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
89 0 3 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
93 0 1 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
95 0 2 10 re
f*
Q
q
BT
/F1 7.79528 Tf
9.35433 TL
ET
BT
/F1 7.79528 Tf
9.35433 TL
ET
0 0 0 rg
BT
1 0 0 1 46.66457 -5.98880 Tm
(88019) Tj
T*
ET
Q
Q
Q
Q
Q
0.84375 w
BT
1 0 0 1 0 9.54785 Tm
19.79785 TL
115 0 Td
/F1 9 Tf
10.80000 TL
T*
-115 0 Td
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 0 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Patient Name) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 64.20000 0 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(\072 ) Tj
/F2 9 Tf
(Mr\056 J JAGADEESH) Tj
T*
ET
Q
Q
q
Q
Q
q
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 30 654.84190 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 0 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 0 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 46.50000 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Age\057Gender) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 64.20000 46.50000 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(\072 31 years \057 Male) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 31 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Phone) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 64.20000 31 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(\072) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 15.50000 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Ref\056 Dr\056) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 64.20000 15.50000 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(\072 SRI SATYA SAI LAB) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 0 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Req\056 No) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 64.20000 0 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F2 9 Tf
0 0 0 rg
(\072 2521055453) Tj
T*
ET
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 321 0 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 46.50000 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Sample Type) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 74.90000 46.50000 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(\072 Whole blood) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 31 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Registered On) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 74.90000 31 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(\072 20 May 2021 04\07215 PM) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 15.50000 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Collected On) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 74.90000 15.50000 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(\072 20 May 2021 04\07215 PM) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 0 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Reported On) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 74.90000 0 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(\072 20 May 2021 07\07210 PM) Tj
T*
ET
Q
Q
q
Q
Q
q
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 30 653.84190 cm
q
1 w
1 J
0 0 0 RG
n
0 0 m
535 0 l
S
Q
Q
q
1 0 0 1 30 632.26190 cm
q
1 0 0 1 1 -1 cm
q
0.91125 w
BT
1 0 0 1 0 9.60104 Tm
240.57190 0 Td
14.58000 TL
/F1 9.72000 Tf
0 0 0 rg
(Hematology) Tj
T*
-240.57190 0 Td
ET
Q
Q
q
Q
Q
q
1 0 0 1 30 613.64340 cm
q
1 0 0 1 1 -1 cm
q
1.03866 w
BT
1 0 0 1 0 10.66378 Tm
186.78660 0 Td
16.61850 TL
/F2 11.07900 Tf
0 0 0 rg
(Complete Blood Picture \050CBP\051) Tj
T*
-186.78660 0 Td
ET
Q
Q
q
Q
Q
q
1 0 0 1 30 596.14340 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 0 cm
q
1 0 0 1 0 -2 cm
q
0.84375 w
BT
1 0 0 1 0 9.03800 Tm
70.86850 0 Td
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Test Name) Tj
T*
-70.86850 0 Td
ET
Q
Q
q
Q
Q
q
1 0 0 1 187.25000 0 cm
q
1 0 0 1 0 -2 cm
q
0.84375 w
BT
1 0 0 1 0 9.03800 Tm
16.98250 0 Td
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Observed Values) Tj
T*
-16.98250 0 Td
ET
Q
Q
q
Q
Q
q
1 0 0 1 294.25000 0 cm
q
1 0 0 1 0 -2 cm
q
0.84375 w
BT
1 0 0 1 0 9.03800 Tm
28.87500 0 Td
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Units) Tj
T*
-28.87500 0 Td
ET
Q
Q
q
Q
Q
q
1 0 0 1 374.50000 0 cm
q
1 0 0 1 0 -2 cm
q
0.84375 w
BT
1 0 0 1 0 9.03800 Tm
15.97650 0 Td
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Biological Reference Intervals) Tj
T*
-15.97650 0 Td
ET
Q
Q
q
Q
Q
q
2 J
1 j
0 0 0 RG
0.80000 w
n
0 17.50000 m
535 17.50000 l
S
n
0 0 m
0 17.50000 l
S
n
535 0 m
535 17.50000 l
S
n
0 0 m
535 0 l
S
n
0 17.50000 m
535 17.50000 l
S
n
0 0 m
0 17.50000 l
S
n
535 0 m
535 17.50000 l
S
n
0 0 m
535 0 l
S
n
0 17.50000 m
187.25000 17.50000 l
S
n
0 0 m
0 17.50000 l
S
n
187.25000 0 m
187.25000 17.50000 l
S
n
0 0 m
187.25000 0 l
S
n
187.25000 17.50000 m
294.25000 17.50000 l
S
n
187.25000 0 m
187.25000 17.50000 l
S
n
294.25000 0 m
294.25000 17.50000 l
S
n
187.25000 0 m
294.25000 0 l
S
n
294.25000 17.50000 m
374.50000 17.50000 l
S
n
294.25000 0 m
294.25000 17.50000 l
S
n
374.50000 0 m
374.50000 17.50000 l
S
n
294.25000 0 m
374.50000 0 l
S
n
374.50000 17.50000 m
535 17.50000 l
S
n
374.50000 0 m
374.50000 17.50000 l
S
n
535 0 m
535 17.50000 l
S
n
374.50000 0 m
535 0 l
S
Q
Q
Q
q
1 0 0 1 30 500.47920 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 -0 cm
q
1 0 0 1 0 -3 cm
q
q
535 0 0 70.41057 0 3 cm
/FormXob.31b2a01266c0423b263008dda8a8282d Do
Q
0.84375 w
BT
1 0 0 1 0 34.60529 Tm
70.41057 TL
535 0 Td
/F1 9 Tf
10.80000 TL
T*
-535 0 Td
ET
Q
Q
q
Q
Q
q
Q
Q
Q
q
1 0 0 1 0 0 cm
BT
/F1 12 Tf
14.40000 TL
ET
BT
/F1 9 Tf
14.40000 TL
ET
BT
1 0 0 1 519 13 Tm
(Page 2 of 4) Tj
T*
ET
Q

endstream
endobj
13 0 obj
<<
/Filter [ /ASCII85Decode /DCTDecode ]
/Length 15157
/ColorSpace /DeviceRGB
/Type /XObject
/BitsPerComponent 8
/Height 117
/Width 889
/Subtype /Image
>>
stream
s4IA0!"_al8O`[\!<<*#!!*'"s4[N@!!ic5#6k>;#6tJ?#m^kH'FbHY$Odmc'+Yct)BU"@)B9_>,VCGe+tOrY*%3`p/2/e81c-:%3B]>W4>&EH1B6)/6NIK"#n.1M(_$ok1*IV\1,:U?1,:U?1,:U?1,:U?1,:U?1,:U?1,:U?1,:U?1,:U?1,:U?1,:U?1,:U?1,AmF!"fJ:FTZmk!?qLF&HMtG!WU(<*rl9A"T\W)!<E3$z!!!!"!WrQ/"pYD?$4HmP!4<@<!W`B*!X&T/"U"r.!!.KK!WrE*&Hrdj0gQ!W;.0\RE>10ZOeE%*6F"?A;UOtZ1LbBV#mqFa(`=5<-7:2j.Ps"@2`NfY6UX@47n?3D;cHat='/U/@q9._B4u!oF*)PJGBeCZK7nr5LPUeEP*;,qQC!u,R\HRQV5C/hWN*81['d?O\@K2f_o0O6a2lBFdaQ^rf%8R-g>V&OjQ5OekiqC&o(2MHp@n@XqZ"J6*ru?D!<E3%!<E3%!<<*"!!!!"!WrQ/"pYD?$4HmP!4<C=!W`?*"9Sc3"U"r.!<RHF!<N?8"9fr'"qj4!#@VTc+u4]T'LIqUZ,$_k1K*]W@WKj'(*k`q-1Mcg)&ahL-n-W'2E*TU3^Z;(7Rp!@8lJ\h<``C+>%;)SAnPdkC3+K>G'A1VH@gd&KnbA=M2II[Pa.Q$R$jD;USO``Vl6SpZEppG[^WcW]#)A'`Q#s>ai`&\eCE.%f\,!<j5f=akNM0qo(2MHp@n@XqZ#7L$j-M1!YGMH!'^JXqC&(g$7MX!$7MX!$7MX!$7MX!$7MX!$7P.-!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:)G?E7`fIA;k@W2=?#>n``plAM-]L-CGU"MpWPSJ'g2&io@hSm!aYpUW<JcdakXP7a!^I>0f0khOhm\MtN7;2kLlCW<T;K+eE-j&KF`G&X@D-OeIX[?[/<-E%c@)nPC+2Z^I$4$#1E1&]G(".>UmcsfP_g5VMnfhAp>"("-T6*.;/-iUTTFDefU4<S!Y&D<`p!/Di("6VJlB_O;hDJ$g!&DhiTH:T^MLn)R!#s9j>MU/c]^\YV5F3a`iO1oNg2YKtK9("N<\K-u6fIJBg$-g6P0U(<Slm"R4K_>f,k?Cr4`Yts>2#VNMC>,!MC>,!MC>,!MC>,!MC>,!MC>,!MC>,!MC>,!MC>,!MC>,!MC>,!MC>,!MC>,!MC>,!MC>,!MC>,#r$c<RJ-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-sHh#+on8Bh`G^d1a26iK]:s_Ln$cYQTYr@.;r^&4%MJCS$U(`YQ0WFaMammd;@1SRDee8BsdLbI;p#+9Dg[$D9<l!McIU9rV7-NGR2?&P19l$T?qK.Da`UL0m=3GlWGk$cQ08Y1[N<*P@ChP>Sh]0-Q1rMCmg38Npr>g/pidE'Mn`/#KYZ\'s_Bf$Y:j'[G3*l>fJh,a(_]P"@L\Z%Qk1W-m`NKjYjh.]O>pau^5?PM^-<mYV#)Ffu7pDfr%/V+E50,.UoK/cOba,K9o1-Z/!*jaG1Z"!!ldQ6%T`e9jb5NGiNZnjaq$j2;_i?S.CF,A/T[i+Enmc!8dUl^Q(e4.AmATU+BJqUeK!b0,FQFWg>>5.ksW4(7X-:"'QA[T]i="l6OTh/3kkEA/AE*&q?*O9bgf#iLSJCZmr7d_&"^QSsmUEQ`JNX<Qd_)bfIlM*Q>2BID;;JcPu`CO>A_\aJF.:%DI[+e<RAa!e(q4apI2a04()-MW#JXX_QN9l[.$'oP_(PFYH^c*B&W+BAn)V_,EM:NO=kLOf#\V"dR39++12G$=It8B'Z],s1VaH$3"a2]S>1U]k+]2t(7SBu3#9oZ!3g!b>>DAltj>:oXhLaJkF'+h;sMD)5P,Z-t@R6fL"a*FM1ECCi^YD%`!78uDiu_4,U%`OI3\j0iK"`oRZ:jCDm-LQ4AL]bRg;1I)p\S)W6qT2laU:;)r1@$8sq:YnU0.nZNOPNL\^/7lZu#3&)Q`7d_@U"$14]KmgjgN\#UO[dfn7l"pJ:?$9fUbS"bUHG':FQZB'D+SjpBaMLUr0=eE2h]:7F4V9Wo00Qm!!WE':^7/4nIZk^\rND3p9<2e!,)LDg3G"*Pu[,u.tS*\1)L)Fag%cA9%.oeD(>8-g2j1JalQc4amuR8L*h%1N:(.S/emti*CpFC^]uh:or<5iSsuM0q3SRV[ZTLP1J4p)N_`gYi\f&<<u)hoH0)BFdr/m1q`7G7PDJTMBhBr)(;c4J&$Q[e7R.h8kD)5DT+GAd::a0t3Z>pX`p`8WaObZGY.u6CTG?E]bWuI9V.OIgmZ6B[=$VX;:J<f2?->$-9.9BZ=Q=N-`pNk?;rs.arU-KeA,cN82O(GH6h\'caAMY8$0D?=mNKBDcj/<MJh,U!GV-<$;3kV/VO#@q&g.E[o0T$D!!!\Y9EI\s@9iSq@=)"08(I$]`8V3GC/`=%n[A"a..1koO9H=q5Qqj!5Qqj!5Qqj!5Qqj!5Qqj!5Qqj!5Qqj!5Qqj!5Qqj!5Qqj!5RGasr$c<RJ-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J2k58?EisCM[#*;>bSaYfj_S%%]q%i!JfAE5W<L@6cYdffg^83G*LAm/$jn*c&KpP-QP!<TE:!!TF*`OSL1*O8KOXPA[1ta[42QEl:WSA51i&P<>[hIVnh9BlW@a(5J5Q"R!qLuIMKC^!+OaY5JoFDaZ\72FID9QQ?ad^NL>j,,]d,Yko(i(-s]"G.`N1O+c>WBTiB4I3lf,-L%:VhpXi!lY,]%W69Rt7nLJAJ>&9Xl(O"3\>XJXVUp1cj7Rg`>Puo+cK4TTN>\BK*Q5(3b3P([cb@+e?UG!lTc<<YT9Is#%5MGs7R#_+!>UrTekHSqK`!s*Y5$c@D/VDXYF6usa/O!B0DQ^/&NGn:KCQ"1-38c8=J(]fYE]>@:mV?!V$7MX!$7MX!$7MX!$7MX!1+2TnLM`rP$2*[<.AL@5*1)eg.h85(GVsfj:pSTDoB^BIm\7uha<_>,qL`*#nRM[jVndrq9_RD:qfii?`p6[pV='E)4U$OoVtPa]E:Ee?BGfO:^u:'i6-i@m4TuiY#Ii)c(9R+&8^M;O2fkqO?&5o@;HRI`<J4b5-ZI@UhDtaC*Z+?8kD4&!88c(%W9GaD+tQN9]7/,.%jSMP3<5YGSoI"6=2#m+1u!Y$J#mAXZ[`RQ4j$7H4UqeC9Du2nrr?Y\C&\0I=oSJ7rrCBsT"\93^OJ6/a'QD[SpYYLW7SZjqNMT[][BB];?nNn`.P6Y0]2@1HGAFR)*`tl(g,YLaK;LK!N23u@P3,o@_RA);EF.IdEiB_a&9.l+>`9V[b#JQfOVIVA5M*%OAA!"cDaV!^CK!o,STLt>Z4,2*]Yku<`U1O5s-'nV<PFW5*p,a=MuDk[Z!]p%_rL%-f2L[j/.kqPGr5E4O^#HBX#!7SD]KP[ckj,a=:!_8grs0Yhj.V?C_3t?YWVbd7aJ@kFGIWN:9F%MR.5B"m*=#>>6*a82hfV\7K+6#iO;dIsYhg*>_5OJ-g'MPtRN4@uFmOmKc"YZ8+J%0V6hG.YU]l!!'e:[/a]d_IMPUrr=hrOoGE4dJj4:<O<$C";!l[&RGT*rr@e`+&Dj@YC3&DS5r$A/+DrF_qW#2l#P)eApDbp2J!4N`.2k^!@Q>2TCEQ7<ReY^XP)g=7JsUT+<=a.2lQI^g]uECYJ^A?&H"9BNsj"dIi$cjPB@:#dQ&S3GtB3_`F4ijV[#=*#!2@5!;F_"U:IgdcItp\WT/R9PdHUriDfmC8N[#YVi/83l$`rRd]IXbH_t(;MFTKQXJpfEQ5S!fJ`%Haf">@*XE[7S$fZXACA,5-Obm3f!?U>?L)DuO'jqO\HQ;aP%nF(=K(@VWRq\Xd#uj$-`5._goH9/"W@Q3Aa5.m,:W&_.;R=cY&Y[u5QNG/=RNoqljnbK%a="a1G/miW][Eq@[uu7.(nP9$2H$fSKdE4[T/qO^o#'cY(G0c(55O:$hU;8Sid4_ZE>2<OZn9T6!QpuE?V540X6H'D7auQ"9/.S5%E-F2lug>-1Y0&H"mXqUMo=I/\^U3JXZH%$<g-RUjhX8`T5e*j^rU$?YM_FeLjh+G`P2Y#4\"<uRN3U3GiQ0AGsaZ0Q#b0#I#:I+#B;aDJWWKO:MY]0DIAKL,tVO-6_oOSQ'ChF,H.RlbTZNDT7K0GGX?gK:VNFSk>/RG:Mp`D5Er&TQ5I]br!dk0X+@A+But3;L>iHJo8or32,^43k<,%I^cB7'VSm2r?>4cVK$ldtI=B(,Hef=_qs7B_H/^iL\AP+RE6<2UQ;c+%oK+#5FWE["qUpcmE>$G6&WEaj62Z]B;1B:)IQOF7I<S@hQ%(BZCUh9;c8Ls5F.P*iUjrb!!-bUSptanQeun[/>1m$6kk]FlfNdLUdbKWBl%NsI$>Zil4B1/ophut0ErQ-;l>/<SU8O5*&"_GrFI:UH:TLCq*<>GC4ADL+gnhEM\#.s95'B@(dQ9>k:&m::!c$9bVl/cUXP/C$[@BqF<UM/8e=O/QOj=6E8+q7g'3apXWiE)@$E+'"h(JiC?cV'p:HV5K!+<F2r=maE&9TVZpmXO^\6F;SF%r6=3*>1PNS+103NZQ<L\qk52")(T,h03W:=^qO-.F7DH@et\UB-UNN&/9b5JTJsC,_7>^)PR>*oV4X^Lh[M.[_bb5(J3F9Td[/G1OHU9b^Gq!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!jMSmip@Dr<q4u2G>_V\,6V.<['D=ES.)-R%gR_kQ/pi08,SQq5O9U2rdc@B1j1U$7.@RUA27mqCE;F&[[-X8CM;iIa=?bTWSiel\?;R=Vo0Kb^8^ug>9r0K#)R2<)\=d-OfJn:'8!tg2:$M?a1CDsn-J>V$[JVsm_6[Eg,&QPQ9_r'QQ(=f47JW7pM7890X\37cZcCXQD\;hl-no9NQcRsO=ocDOPhPOq3-=6;Fgl!cO4u]`nhiMd-mm[2!@%bI:O[r@4<uWmGN]S_R!_S%J$$P%g(A%57;3I0CUjESYaIEod!,g7W"ktVsY5Q3QTMa"$#QNTIiksnXbjGQ>(NOen4VTL=k;79,NrLJ>ro\!cu`Hp#C[/mbnbJk6`tfJkt;0-G2:Th\YBipq/9M+%g<1[@/XPZ5CB"ARoKdo_F_0p%`oQ#;tq6!R"UC7I[ITi_T>>D7)8_[eGjLdTXm5%%rn(A-7>mHJ$gAbr<P/9Y.+'E\6Y:^j.goj!Oq_"J3;\GXo_Y)Wsb/+!,-+D:OBC4B!pO!u&:9a4i\?kH<n]gA&9^\+,N1oaOC:k-28@-+hHDMhtnS<65%a6RL`@kFrl\rQ]?I\C1,^J$&']INJ#KOlEDdH_Xh=EGN(_Q*$mB8KDbU7XkctY9s$=W6M,c$V`tE_JAu7rm<!7YRd=+%bOXpr^Z0u;GZg=?IH7=#MNohC$mkP<M%D#dTbM[DIl,GFH)EK4]QR-o^-L2@T1_<X\iD9ikL:qkD+L6l(/d$e*Sfj[29ZMPUe#QgNnQ,\;e+^'&.Y/GU.>O]Ag#MrZ1Jkm^]913[3B_h@u+i_n*Odg(m[49TPR2K?asG\E.hBqUkHZMW/`c[s=b^'L@m,NMLL/<"aZ]>^hgpD,Xchr%3,j?"pSb9c@f`p1O1G;=bJCB*DPAB0#([gBY)K%1QDTV`E_^*r'ZmZcru6I3mo@O#2bdO]+9[=c`ZS*rW.8Y6=fm5LoP(rVLO3X'XD\l8*,m(&">>@5[uVn?e>3^cm$G%MWl3Onp,`4U5h?BMi)/5K(fn9%SG4BrOCr\FBYNcXlfa/adGa18*I77``amAQLr(:=o0b*I*@Wrr<aTT+9aKVC%;&83Y@Hj@EV\j3'YN2t#D1kVoPP[/rKDMWEmNFk]mc-3!ttiRBE#mE&pXB`kI21'J(UmE>h=lm+3(Xh`\DaNsB4?IH7=#MNohC$n)Kb-TcLRS/!s/^1.PDNV4[`u.n&_pbh#6e83>2";rRHqU=6;R#YNR:iAP-D>0eKr<fGN8dXG_2'3NbAb!:NkEkJ$M!kI]N_1VT%mK5M6CU`m"e,k@$plE>SdMU@puu6`""cg?V?*6:nkV/_ESX?NtlmY:t6-AOR"h!8Sj])g%L2A'a&pV3-J[gE#/u"`H3$MLpcP%&aA!`(9&3FB\+&(gpSt0B+[tYW<,NApIWJJN2XS<6NaZh\1`QM5Ip=8RA_(jH[)_F/j-%Y;LGHCkA)\A,GFOP*r$cC!-iG#qe\\"!9129oc#J%=1Y`eAVf/:#+[QMm@/+3$hJ<n`bSB0(5o8A;81I8XYRoab=8q)bBJGa"$t3d!_2*.+E%/i#pYNlY?mrR4D3Z>NGq!Oi$^G,,>bqUdO#0>D.P9?'LC^\,ufN62][/;($L*%f/6hI_DCJ'*g84QHo?7Ni\i1H+Cq/@N\e`rrAh$DM?(rNAs6<crN+_,M7/T8fii_o3AHh,R1;`'Oj^noiEq,C*t*=W`%-)\NAB)ONB0#[>dFA0XWQqH.[_?\4'/Q35]f!S*Vc,B*ZQ)"p()qTe]l@abE"5X]X/OTmm;*5*X4V/[erjn>PO]*>)&#W#FBW@5Y02?lE0^f!W4HId@*=G^VR)^C478oLcWnF0$Cn)5p441$G.9f+2mO5T&?fKD!M!GfBdr/ko(kGLShZ2/tsq=W%,7.Rk;YK\hFpG*_t[TI_QT(_!j?m^PhfFrr@_FkdoM^bJCba.cH0\HMN&4-KF];d_.O9>s7q=[!a`(dWL&Fbp89oH#]_-"Ato3j]=2enm!iWDY;UjQ@M*7f>`7qe9jK_gr\MJX%V1f7bqo5eJVQU'/G>JYik'VQQIh!4CY7:8^TAu*-c_9LPN8Jpdnbd96YeF=BuEp(eGlIRmQQ(YohdLN;DcQ:^;f(6dYKc[4d:nWFMml@n/9P]&MSl=dK-*$PKI[:<#9Zq:BWV;('*QA#`bd=l*Fh>pO+m2YPGe&m\9_#"ASQc8#!pif](q,L(TniM5BSJado";7=!ASZQ'29;imYMGV9S[]fmbgJ8e/A(IRQ8#5H3ItSr2`$m0B5`KI\;?kqs#jmS'glcu&<Fb[)7&6Id$1PBWWaBOK'.ohNe85E"Z\o-mXJLe72`/#jR6Vj>HLoBXBQ\ss#(Hn#%I8Mtp=!l'Ko;3Hp5_"U[P5Uh@<-T?)gSW\BZ2+)kH]>+pnQc<Ne)Cln6R`8$HBEG7Z-1^(sYT@bV4I%or%^6ZdiOS23mm@$XZI,_\09BA[dW&M,1,4NdHKul!%I;n@e7rXQd<MT87Em_.k5e@=n_27i4?%JA\])f^u>$h?^58U:5[VE5[;>'QC&V!$?nK5'#3tnMc=&%H8U^iI,/e;6Q-RX^SLigW(1?Q:(]j,U[cu__s6j)6\,N:mHD=TuT='p<uNA$uZjD;:Up5O?r-PXmAnM*0aC<HfM57epA@u[^jk[[4a+j_AN\D_0+U9Bc)!U3'$"Vb'Yr59uheP]L?n?rMf2C\nEWl@sJB:m3Y7i#:5.k%L4%XoWMDlJ35dKKpJX2l[C/Zda>I,1OR:;`o>!?eb5C;)iF#i]K22+\cLf?&9s]'O,:W[Hng,K?HX)&V6.C2P=X-iN:$F-QL4ci"Xhcloc-hd*h[b=_J?hd_I!iBlmM;b[edntaXt3$C%B9IR*[9;15&MdF-E1V*])2k+8C84i8$HjpK/mCX/N=l,=W(c6';6nK#Fq>1,p$5Zr(cL.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!o=p4_):j1DiJ;T(*m;cl>c#>2,cHM!<uC#]4HA(gY=,+84M+J[a,9QILDjfX'%5B*N@h:"n#pB6&fn62aGCQj,d)T*]Q)gQD\RR`Sf`V-n:c+)gtYGJZ0"\'THm&RB4=YW%g1G1=*Y"ZUtj4;%DJ`O/@Ls*.36:36]^\dIU8T1r=<8&,G+DDQDLJR'2I#J"G9UYYY/r@Y[fL5"U?MQb"2Bg\P4^.i`uI"dj<P1an=t:@*OO=6pkbO16BL07S`(J!0NNoTs%.aNjfLa4P.V;):Uhpf\#G0pjPpk_fE%SW*N%(q/PHX=M2+T@X-j`NWD9HH92cS/5eBHX26;'Cj$[=BBj4':^7uO'`.h0L,HXL>14PD)sM5Y3=M%k!-]uRJ9Z2^*-B?r22Q&*HgLpnbha&_m$?g6]sa&@*@+$K3^N?n0d@eL.)7*^*@oL1e80#@DChHo\!H=6Dk@)'XRTqc\O"C$[VF>>Y,jJHmWhlgHo^4?%t#M4nF`'P>3jQeNGUnMN>lb_O:H:QBj`\NS/g-6ESqoWa_ft*[.*IWh<>`XF*O>2.ahQm?8cM/E\Wk7o7H/'VCUP;WkPqhg0!q7&pRKr(]OIPF<;4OC!.fWSSYQ)"R$_mpOql9N.L+$\BYP0-E6s9/X'<%;F%Hn")I#@iI(%NJqH3X);oR;CDXoQ(".J+Q=EjJ<bj^Kp@:R,`::A*)+Z"P!3JnjLXtW7n:SS:*Z*5s,eCU7Q2>[M=llrg$9;@i,NUJmM$&Ba2<ZtSaUPl('tfkC3^jo_>Oc/-lUu)3%@sS$f("RTM#p/!U8Sn1V4iJ#IgJ4ZifAlp!8?b<B]@rW(lB8JW6X4go:<gLG^`Z@?UNl@6H@&(2YP_uD="^X_5'IO7"b_V1,3ZtfJafN_Xkc_\\,S_e*SEm]t&mOg+eq_B`]K=S<Laf+dsp;,G#2S=Cb7m+u!S>,9VS!Jih?P"2Sk;"63N9HkUUn*OK%a,5&*W(]-X)98O%rm4>D01>Z@t/p_hQ]Dhkgh?g^^[tGA539(pjUoQA^c2buFf5\hJkI2ok^8eB8fZ0r2VnMK/hT1F>[V8]3auZb3jGja-D@8f>>10gZ5DSu:DhbD/lRN/`Sl-9E+ZY\VcoYgaH>[WNjYn4]nZ8%j$+`nBg+D0DI+L<8rM6PA`.d5pQ<,:KD_IUs4ZtN+qaDNC(=L6klM_RNY<FjXIOe%p3c0kSg#XE"gfUYNPm!%rAK>`74ERO9)>IiEn8>/`bsu,q)bWj"L!iY4&?KWK+ZmtoiPEi8%lNT1\(7!bUYXh`6#1<Y2pFI9&TVhGa+;>7nYe=I)T0KS4jK=l_<9M,-s7eM=#_=_7jA-=penN.)<]isn2Sn21$a/)XiL?3AqE+pMDdOj`1,AM`rjP(@4Kd`0@@F>W-h4amk!fJe@[_U*r!(6kX-!/o3pE_M\XAG6FJVg%S_-c-A>meh)-`?ka`l%F!Q_i2?6U?@S+G:W:UDshuR"\qcf`*h"&dE?4cWKKQRe;a/mr[*PL:EOrK(E2jcmKLb_<TkN3nI"qOSrFAY:C'UREX.eo"%pj??%>A5!$&O"Rs8n*.8jVsF#;n*rTn-I/%Oi;.OL0iV?d]^%4lc<r$Q-Ij[h+7'.L*oeaYrH.1:Da>,jFN>78ETDS`4]M`]7t#V4`1Oa[nsre/LH<tJKS3ZKOjPk!B<()?&Vt#Y,m@@0&U!1Lk!jGq4_1$aDpd7T"sE2`@c[;\ad[tBVp&c\/#Hlp1Ml;LAO#']5A#:(u=cOqk3FRBlCY$Uf_Au)IkAk\'RG7L:;cW=*IBn7_fi&kIAUkjGNQB+IG>&hfp(9c;ERLijcBh(5S9ESjk.YBCA?V"Nf"uP!sK((6s6Dr()AdMWS$Cr%W,'f7k+4jHUuN)tAO4+QGKEQlR.f0[_TG>ru&mQ:mT&(\6r+(s.&1$qc*'NK'Id%AtP9Ii7JDQ481cpK"Mpd'RjGUq'W'0F/#)1;F)V*:QKASd.U2/<f%AKk96EWp'&lHZ:T<EML?%S,'?$lq723<U`Wj^Ge<U4^Mu?pYf_gg4Z*PIq$qOGd$N%8fQN,OsVu%!tBgkDI8W]a<V1U%o7%\9p8n%&"23f-J7,L?<aRAh7%?NA#[KR2<O`gMjM:&%pnMfmdB2'=Lko"LuadL2[+6g!U($r3Ffkt)A[Y4^8LLacVq3*nk0k54ls^Kfd$pDXoS[eEiO)-@K8U"JU)*TDt&MOkH_aNgM=go<0l@fKO8I)]I=^K["FM0k\5NRL`V\"j"3%AW[rAC:2QHeXjYWdR3>M9]-@<nO?`qZp'-]?a#X[B3_[QU=,U,5Cue67$H\B#k84F+meuThjgCXs/+4@pB.OkME*hdS[?BCgf&le;\*hIkG=IHJ^>,D$ZG[0/`R#N-h['-;(=lR8$Tn"t%(;>dM\3O`:>B^0J\.gdGW9)T'7<0q'1(1A38i:,[&f1T7^J4)6aq*%68GQ24,s:]EE^'mf*@,E4(kMf;T0od,>,7GaUm<*1"mTKbKgSP&#l]J:t'@E^\G"@_X+DlKM-(:6fR$^<`0Lh%!Q^2H*4cp3fFuDJb4/qo6/)e$nPqGUWY3')]O=K#9tIPK?k54bh^qkc])u01?pp3=?_H4df__.`(DBJp20n9A*)_QO(r<Yr+.,lGDT[/e0VcUoW:sD=^SK1O#iT\WK\JdA?R+s\u!0gi7<?8[(;QZDfitF6lp3qM38B/9tp^s9((D]I7L\[Gj]gh1Z6oO_b7FB,eA[T.;0ue`\RF[E=`s50p0Kb60B(-)@+:Y=L?Xi0j]d/*EB9/`OdtL(hIZ]+G)\-J^fc3M")RDiUI/.4;"\1\?tibb6GIZA!SOYCq0PU!_!4o\7BU1N?!e&>N7+`QW1M47nA35k.?41dsg^]>NS`r(>oTL-glpnG\!.Apj_f(3t!#'rrBCu>6/bFdSJ]p6'aid?A_2[FO(iG2urSV+3$?2ZR2Ra00Qt:@395WfH/kD;@>":i"2[cEcK&gDrY[Uip+AbCPWd(rrA)tkI5-b\N%kLLu=EB2@8c>j1ImUlC,`'j3(('H^LVBdOh2F@gai/3q"X=\H,8FJt@55Z)I>2J`C)GG[F+mA"#PahYu)!W'%Lk2"*"kp6-V8a!#M`ghk:A)6r/TQu"r/HpO4`j3+j=2K$htKWJnK(LrVQ)(^7UkcHsQVHrJ1\pFgcC%!9%g&7f(UDGBa:;TLt3@]"#k8!0/-LgH.XLH.&CC;YHP4S#NC=5MkQNAF1lAS1Lr2"Z+7XEY*ZZ-M9hngU1NJ5WCWt"ae8JtR78Ac7(?9Uk,$5E0u3!=d73igREB_F/f>Y?l\St@ZuH$'g4j+:'nj_Ss.gpu,E>k<mmX`^[hHLJf/*D;dfrrBGQ1VT@@gW^KfN$KZ&"7CfZF3#JE%<8?^W4)5^MW\-LZIJP==n_'G2\#on',?Zf.>G[l_(#^<3Pa=t!bsnSpjIXf_`c;5!5.,ME4JN(_6H@tI&B)8Y]:$7-jFdg`L;.t&L4o4>3kNjEgH'$1N1oIG@2@7EPgdE&pUMH%s[6o?h#2<V8m.q!4.nW)p;kLmlP_JAh1;RfF1&/Hf/q`L7R<CH$h3C>n_@\&%D=Wng8JddX:Z+#i-DN9UilN:-%O9?c%"/@ebf?%6eGQ'AQm4EuFP<B9Zg)53ubs"Ei":E,Zp_!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!keEN[o2Kt0(>ckbc`%AX!I8n#g!9QU.sKA5M^3EHWQll+lc?.?f1,e-]#-0MG7;DRGL#N?XheYlaB@YA*%/\1#O+[])e\1GXG!Q]KUFoCou]S1rZL@5^ep<h.-U)_#o7IoK4%Ho>LAYC>+E1TkTF`h.`gKGU9lj'ha/%)BGrja;N#*1,?Yq]7!m\]L>68YAE<?b?_JZ,5!<oKX\0+H=UY5SZpR#?OQYt`&I4#QPtmPXSGp'f$[(&)3IOs0Qp]Uc9WE[LXr(okWQX+=j*Z*3e`<VGBFD!FnS6tW_!W62Go^2]F'eH(V\ffWNA:2(q/rhe[3G7/pohbgq^4s]?u_QAQW>OJEV;#outJ7m:T"snCW@bP31_Gkr"GfaIXufn(os^m("5oN]?i/CKbG`eZXlnF/[4>f=A9=,IJ<79.U6a6ui$?KPrj+PE!Hslfge3I/a3*^Yj_=]YEFNNX]o+&5On7NtS73`o]9uD`m7F"8G4t>W+V'A#9RnMGe]id54W.lJH'\2VRQB(9ib#kal.m=D+N:3$tpn45jt75?bfr.aIo^nGUUaUY&krY)@>F_aL3QBE5L/5WK\,35QRmMC%b9K/B@^S!9C/eL]jnc-.9B8@N0*q=$j<]N:6rcQk)lYF$8CG:o<R)oicGeq3$tFLsP$42Q8r#s,?Ue#tkDLS\5&]P"38i6;?&lUm=g7oh?5!iq$7h9`]U,:*m),k+P66VW>,e`QDBMQUL<k(:cSe)IgF\TqX6=V\cqLFbH73:(rl4e8L/D7g\DI5L.(WGc27_5UVSG7m\jMM,OX3$)Dn]P[n`"9mkbhU[2-XE*1`qU$8.nH%S;cG-@6B[R:5%VLO]dQ,jBOJ.:XKFFgg3SG!M.b1_]kEEiMH;37Q4fW64O)\YaR97[0!pW_Z3+,3O3TgX)j(7`*]a'=?Fem[b=N$Z0JZN@5GS2^4)D45C!uO&cSt!=C5s9t1F5p%#l2sDb93ja8i[_K`T`*9#&Oumh>6RcAT"J[7H1kU/-2DicBXcn1&o,-*9k%s/a?UouVmfB`L02B@=((Gl"I"cW:JR17nTl-7-Lb9,O[ARK&DO"8<<RS[4+Y`IS.(Hnf'im7X(]uJp,DhX_[O,Yc/^fQ<%BFh^o#Hb3Q=Y3(uqbo+o$nkCDsV\!/8F\Uec1UT<#eXE?\$_!/OB8%cEZ9diS0c?9^*i,M)j+5DT6^4tL$tpeiCZ(gSq7r0D>bCG!u>a-V@bS1`T^c[P#f*Ab`W?>>oC(KrUug?[,-2OuP3hW,l!`2U*H-$^>>Y+&9Inn<5[:0!3LCM,QbC_2cs4*P0Z!O86(jq\jN^\tFqh.C"&>`D(hVG0tJip%;JBc[nVbAScN%)d_I7RF"<B'a*N]M#:"K>Cn,<r0_UMTfG]7RW-N0UD%qS8q1IRlrrOB8Y(*[u2WAO2;eUerMXGg6S+Xde(\[FHOEXK-98A;34AkoG'Z6?%1Bopjo3;LHNh^gtl:>>U8flOA-@^O.!fe&4sqC!-oplfM*`!(Olr8k]^6QGZesGSHnS>K?F2oSt@r(nX_o=UqRCeRb+,kROpT#!*QSST(bY%jH2'4(>paF,<1hFN/Tfs$jeK"FPn2r:Jea5e@m2Q)ZJ/^/[`iWoW^qOM&@K[r^O6$XV8Vk%tjQD#E:''aQ73)o\7IJN'u&fP!%RG(_pY"g`ALh]r4%HW9G?Gn4gU0K_JZ!O/L6:F*Nj;TJVOaSZLeTPU,0.UD]sGhtk\t?,*L=HKX8oO%,>OG5=S]phhN`,eT.Wk7q&HAQZD=d=MljJ\WXN.p?j)XSUF-7Ze*\QZ?2f6ZeM/U@MHqW=0Mu,j,7M#:+;\2bDAD7ATi>e3"#j6dI2SM`Y31ArK#$;\m<To5@O=c<"^E.)p>H\%6/=Q/YFEI1&fa]6u>%L;lm"52tBEgUQ6'(4VF)+CU=uDES"<#H;nH!9,<+h[f1g7jj%p-*`$>9a09<"HV\jA7.3T'u1&)SqI2MpYI1*9m5PfdkpjgDJ^uRk2@BF6H'qK;&J#2\&`WRW\V=J4E8(Xd][dhKpn'VZsO5K>$hMjMb3=[@RElP)%<*F;j+>UGA">i26#U6'R55h8S7J3U\=I7_eIi$Ku?ha$^Erg/`m*ga5&phodS]+=dErQ<NH]PBf\(s8J]e>cZ^KeW-3!M`XX[=EU1^oTZ94'H1U9L-+!,;L,E\HNi@"6OS1W=`@=?V3uH9:gd0R`Cm>.n_O^pW%6sV3$7MX!$rMm1TEN'*'N%+'MG+@*TE>n8;*Y=6`=u,M@Z4/Q!#VIF;*Y<h/JM"_?r;e0TE>m;MC8Rd[.&7FVTp@6r+2fmV=/X*1YTYrTXtt!Q'@l9rSY`Q]":$`Ci*),!(&;5=QH_7-&M%],a7#I72,bd.)cls!msFN!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!*0:'!/#B16WTORA@o:aR8kT*b4]U_PV3EZb@TL\`_SRgM?)/T[*)/ngW6a\Wg;H,m`tA]!8Pl<ZQ&s#8N6h#XjKQ;'N%:!'N%:!J,e1~>
endstream
endobj
14 0 obj
<<
/Length 8954
>>
stream
q
1 0 0 1 0 0 cm
BT
/F1 12 Tf
14.40000 TL
ET
q
q
1 0 0 1 30 836.63980 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 2.62500 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
Q
Q
q
Q
Q
q
1 0 0 1 30 716.84190 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 0 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 0 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 17.52393 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Client) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 64.20000 17.52393 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(\072 ) Tj
/F2 9 Tf
(S\056R Medical Center) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 428 15.50000 cm
q
1 0 0 1 0 -1 cm
q
q
1 0 0 1 0 0 cm
q
[ ] 0 d
BT
/F3 10 Tf
12 TL
ET
1 w
0 0 0 RG
1 0 0 1 0 0 cm
0 j
BT
/F3 10 Tf
12 TL
ET
0 0 0 rg
0 J
q
1 0 0 1 0 7.54785 cm
q
1 0 0 1 0 0 cm
q
[ ] 0 d
0.00010 w
0 j
0 J
n
0 0 115 10 re
n
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
18 0 2 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
21 0 1 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
24 0 3 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
29 0 4 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
35 0 1 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
38 0 1 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
40 0 2 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
44 0 2 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
47 0 2 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
51 0 1 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
53 0 4 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
58 0 3 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
62 0 3 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
67 0 1 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
69 0 2 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
73 0 1 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
75 0 1 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
78 0 4 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
84 0 2 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
89 0 3 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
93 0 1 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
95 0 2 10 re
f*
Q
q
BT
/F1 7.79528 Tf
9.35433 TL
ET
BT
/F1 7.79528 Tf
9.35433 TL
ET
0 0 0 rg
BT
1 0 0 1 46.66457 -5.98880 Tm
(88019) Tj
T*
ET
Q
Q
Q
Q
Q
0.84375 w
BT
1 0 0 1 0 9.54785 Tm
19.79785 TL
115 0 Td
/F1 9 Tf
10.80000 TL
T*
-115 0 Td
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 0 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Patient Name) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 64.20000 0 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(\072 ) Tj
/F2 9 Tf
(Mr\056 J JAGADEESH) Tj
T*
ET
Q
Q
q
Q
Q
q
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 30 654.84190 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 0 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 0 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 46.50000 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Age\057Gender) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 64.20000 46.50000 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(\072 31 years \057 Male) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 31 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Phone) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 64.20000 31 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(\072) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 15.50000 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Ref\056 Dr\056) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 64.20000 15.50000 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(\072 SRI SATYA SAI LAB) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 0 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Req\056 No) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 64.20000 0 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F2 9 Tf
0 0 0 rg
(\072 252105545300) Tj
T*
ET
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 321 0 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 46.50000 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Sample Type) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 74.90000 46.50000 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(\072 Serum) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 31 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Registered On) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 74.90000 31 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(\072 20 May 2021 04\07215 PM) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 15.50000 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Collected On) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 74.90000 15.50000 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(\072 20 May 2021 04\07215 PM) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 0 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Reported On) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 74.90000 0 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(\072 20 May 2021 06\07203 PM) Tj
T*
ET
Q
Q
q
Q
Q
q
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 30 653.84190 cm
q
1 w
1 J
0 0 0 RG
n
0 0 m
535 0 l
S
Q
Q
q
1 0 0 1 30 632.26190 cm
q
1 0 0 1 1 -1 cm
q
0.91125 w
BT
1 0 0 1 0 9.60104 Tm
232.74730 0 Td
14.58000 TL
/F1 9.72000 Tf
0 0 0 rg
(IMMUNOLOGY) Tj
T*
-232.74730 0 Td
ET
Q
Q
q
Q
Q
q
1 0 0 1 30 613.64340 cm
q
1 0 0 1 1 -1 cm
q
1.03866 w
BT
1 0 0 1 0 10.66378 Tm
197.24520 0 Td
16.61850 TL
/F2 11.07900 Tf
0 0 0 rg
(C\055Reactive Proteins \050CRP\051) Tj
T*
-197.24520 0 Td
ET
Q
Q
q
Q
Q
q
1 0 0 1 30 596.14340 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 0 cm
q
1 0 0 1 0 -2 cm
q
0.84375 w
BT
1 0 0 1 0 9.03800 Tm
70.86850 0 Td
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Test Name) Tj
T*
-70.86850 0 Td
ET
Q
Q
q
Q
Q
q
1 0 0 1 187.25000 0 cm
q
1 0 0 1 0 -2 cm
q
0.84375 w
BT
1 0 0 1 0 9.03800 Tm
16.98250 0 Td
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Observed Values) Tj
T*
-16.98250 0 Td
ET
Q
Q
q
Q
Q
q
1 0 0 1 294.25000 0 cm
q
1 0 0 1 0 -2 cm
q
0.84375 w
BT
1 0 0 1 0 9.03800 Tm
28.87500 0 Td
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Units) Tj
T*
-28.87500 0 Td
ET
Q
Q
q
Q
Q
q
1 0 0 1 374.50000 0 cm
q
1 0 0 1 0 -2 cm
q
0.84375 w
BT
1 0 0 1 0 9.03800 Tm
15.97650 0 Td
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Biological Reference Intervals) Tj
T*
-15.97650 0 Td
ET
Q
Q
q
Q
Q
q
2 J
1 j
0 0 0 RG
0.80000 w
n
0 17.50000 m
535 17.50000 l
S
n
0 0 m
0 17.50000 l
S
n
535 0 m
535 17.50000 l
S
n
0 0 m
535 0 l
S
n
0 17.50000 m
535 17.50000 l
S
n
0 0 m
0 17.50000 l
S
n
535 0 m
535 17.50000 l
S
n
0 0 m
535 0 l
S
n
0 17.50000 m
187.25000 17.50000 l
S
n
0 0 m
0 17.50000 l
S
n
187.25000 0 m
187.25000 17.50000 l
S
n
0 0 m
187.25000 0 l
S
n
187.25000 17.50000 m
294.25000 17.50000 l
S
n
187.25000 0 m
187.25000 17.50000 l
S
n
294.25000 0 m
294.25000 17.50000 l
S
n
187.25000 0 m
294.25000 0 l
S
n
294.25000 17.50000 m
374.50000 17.50000 l
S
n
294.25000 0 m
294.25000 17.50000 l
S
n
374.50000 0 m
374.50000 17.50000 l
S
n
294.25000 0 m
374.50000 0 l
S
n
374.50000 17.50000 m
535 17.50000 l
S
n
374.50000 0 m
374.50000 17.50000 l
S
n
535 0 m
535 17.50000 l
S
n
374.50000 0 m
535 0 l
S
Q
Q
Q
q
1 0 0 1 30 549.88980 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 13.50000 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 5 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(CRP) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 187.25000 13.50000 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 20 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(0\0563) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 294.25000 13.50000 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 5 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(mg\057L) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 376.50000 -0 cm
q
1 0 0 1 2 0 cm
q
0.84375 w
0.84375 w
BT
1 0 0 1 5 20.53800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(\074 6\0560 mg\057L \072 Negative) Tj
T*
(\076) Tj
(\057\075 6\0560 mg\057L \072 Positive) Tj
T*
ET
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 30 505.38980 cm
q
1 0 0 1 2 -2 cm
q
0.84375 w
0.84375 w
0.84375 w
BT
1 0 0 1 0 38.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Interpretation) Tj
T*
(Elevated CRP levels are seen in inflammatory disorders\054 neonatal septicema and following tissue injury\056 CRP levels can be used for) Tj
T*
(risk assessment of cardiovascular and peripheral vascular disease\056 \056) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 30 489.88980 cm
q
1 0 0 1 1 -1 cm
q
0.84375 w
BT
1 0 0 1 0 9.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 30 464.38980 cm
q
1 0 0 1 1 -11 cm
q
0.84375 w
BT
1 0 0 1 0 19.03800 Tm
231.73300 0 Td
13.50000 TL
/F1 9 Tf
0 0 0 rg
(\052\052End of Report\052\052) Tj
T*
-231.73300 0 Td
ET
Q
Q
q
Q
Q
q
1 0 0 1 30 387.97920 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 -0 cm
q
1 0 0 1 0 -3 cm
q
q
535 0 0 70.41057 0 3 cm
/FormXob.31b2a01266c0423b263008dda8a8282d Do
Q
0.84375 w
BT
1 0 0 1 0 34.60529 Tm
70.41057 TL
535 0 Td
/F1 9 Tf
10.80000 TL
T*
-535 0 Td
ET
Q
Q
q
Q
Q
q
Q
Q
Q
q
1 0 0 1 0 0 cm
BT
/F1 12 Tf
14.40000 TL
ET
BT
/F1 9 Tf
14.40000 TL
ET
BT
1 0 0 1 519 13 Tm
(Page 3 of 4) Tj
T*
ET
Q

endstream
endobj
15 0 obj
<<
/Filter [ /ASCII85Decode /DCTDecode ]
/Length 15157
/ColorSpace /DeviceRGB
/Type /XObject
/BitsPerComponent 8
/Height 117
/Width 889
/Subtype /Image
>>
stream
s4IA0!"_al8O`[\!<<*#!!*'"s4[N@!!ic5#6k>;#6tJ?#m^kH'FbHY$Odmc'+Yct)BU"@)B9_>,VCGe+tOrY*%3`p/2/e81c-:%3B]>W4>&EH1B6)/6NIK"#n.1M(_$ok1*IV\1,:U?1,:U?1,:U?1,:U?1,:U?1,:U?1,:U?1,:U?1,:U?1,:U?1,:U?1,:U?1,AmF!"fJ:FTZmk!?qLF&HMtG!WU(<*rl9A"T\W)!<E3$z!!!!"!WrQ/"pYD?$4HmP!4<@<!W`B*!X&T/"U"r.!!.KK!WrE*&Hrdj0gQ!W;.0\RE>10ZOeE%*6F"?A;UOtZ1LbBV#mqFa(`=5<-7:2j.Ps"@2`NfY6UX@47n?3D;cHat='/U/@q9._B4u!oF*)PJGBeCZK7nr5LPUeEP*;,qQC!u,R\HRQV5C/hWN*81['d?O\@K2f_o0O6a2lBFdaQ^rf%8R-g>V&OjQ5OekiqC&o(2MHp@n@XqZ"J6*ru?D!<E3%!<E3%!<<*"!!!!"!WrQ/"pYD?$4HmP!4<C=!W`?*"9Sc3"U"r.!<RHF!<N?8"9fr'"qj4!#@VTc+u4]T'LIqUZ,$_k1K*]W@WKj'(*k`q-1Mcg)&ahL-n-W'2E*TU3^Z;(7Rp!@8lJ\h<``C+>%;)SAnPdkC3+K>G'A1VH@gd&KnbA=M2II[Pa.Q$R$jD;USO``Vl6SpZEppG[^WcW]#)A'`Q#s>ai`&\eCE.%f\,!<j5f=akNM0qo(2MHp@n@XqZ#7L$j-M1!YGMH!'^JXqC&(g$7MX!$7MX!$7MX!$7MX!$7MX!$7P.-!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:)G?E7`fIA;k@W2=?#>n``plAM-]L-CGU"MpWPSJ'g2&io@hSm!aYpUW<JcdakXP7a!^I>0f0khOhm\MtN7;2kLlCW<T;K+eE-j&KF`G&X@D-OeIX[?[/<-E%c@)nPC+2Z^I$4$#1E1&]G(".>UmcsfP_g5VMnfhAp>"("-T6*.;/-iUTTFDefU4<S!Y&D<`p!/Di("6VJlB_O;hDJ$g!&DhiTH:T^MLn)R!#s9j>MU/c]^\YV5F3a`iO1oNg2YKtK9("N<\K-u6fIJBg$-g6P0U(<Slm"R4K_>f,k?Cr4`Yts>2#VNMC>,!MC>,!MC>,!MC>,!MC>,!MC>,!MC>,!MC>,!MC>,!MC>,!MC>,!MC>,!MC>,!MC>,!MC>,!MC>,#r$c<RJ-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-sHh#+on8Bh`G^d1a26iK]:s_Ln$cYQTYr@.;r^&4%MJCS$U(`YQ0WFaMammd;@1SRDee8BsdLbI;p#+9Dg[$D9<l!McIU9rV7-NGR2?&P19l$T?qK.Da`UL0m=3GlWGk$cQ08Y1[N<*P@ChP>Sh]0-Q1rMCmg38Npr>g/pidE'Mn`/#KYZ\'s_Bf$Y:j'[G3*l>fJh,a(_]P"@L\Z%Qk1W-m`NKjYjh.]O>pau^5?PM^-<mYV#)Ffu7pDfr%/V+E50,.UoK/cOba,K9o1-Z/!*jaG1Z"!!ldQ6%T`e9jb5NGiNZnjaq$j2;_i?S.CF,A/T[i+Enmc!8dUl^Q(e4.AmATU+BJqUeK!b0,FQFWg>>5.ksW4(7X-:"'QA[T]i="l6OTh/3kkEA/AE*&q?*O9bgf#iLSJCZmr7d_&"^QSsmUEQ`JNX<Qd_)bfIlM*Q>2BID;;JcPu`CO>A_\aJF.:%DI[+e<RAa!e(q4apI2a04()-MW#JXX_QN9l[.$'oP_(PFYH^c*B&W+BAn)V_,EM:NO=kLOf#\V"dR39++12G$=It8B'Z],s1VaH$3"a2]S>1U]k+]2t(7SBu3#9oZ!3g!b>>DAltj>:oXhLaJkF'+h;sMD)5P,Z-t@R6fL"a*FM1ECCi^YD%`!78uDiu_4,U%`OI3\j0iK"`oRZ:jCDm-LQ4AL]bRg;1I)p\S)W6qT2laU:;)r1@$8sq:YnU0.nZNOPNL\^/7lZu#3&)Q`7d_@U"$14]KmgjgN\#UO[dfn7l"pJ:?$9fUbS"bUHG':FQZB'D+SjpBaMLUr0=eE2h]:7F4V9Wo00Qm!!WE':^7/4nIZk^\rND3p9<2e!,)LDg3G"*Pu[,u.tS*\1)L)Fag%cA9%.oeD(>8-g2j1JalQc4amuR8L*h%1N:(.S/emti*CpFC^]uh:or<5iSsuM0q3SRV[ZTLP1J4p)N_`gYi\f&<<u)hoH0)BFdr/m1q`7G7PDJTMBhBr)(;c4J&$Q[e7R.h8kD)5DT+GAd::a0t3Z>pX`p`8WaObZGY.u6CTG?E]bWuI9V.OIgmZ6B[=$VX;:J<f2?->$-9.9BZ=Q=N-`pNk?;rs.arU-KeA,cN82O(GH6h\'caAMY8$0D?=mNKBDcj/<MJh,U!GV-<$;3kV/VO#@q&g.E[o0T$D!!!\Y9EI\s@9iSq@=)"08(I$]`8V3GC/`=%n[A"a..1koO9H=q5Qqj!5Qqj!5Qqj!5Qqj!5Qqj!5Qqj!5Qqj!5Qqj!5Qqj!5Qqj!5RGasr$c<RJ-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J2k58?EisCM[#*;>bSaYfj_S%%]q%i!JfAE5W<L@6cYdffg^83G*LAm/$jn*c&KpP-QP!<TE:!!TF*`OSL1*O8KOXPA[1ta[42QEl:WSA51i&P<>[hIVnh9BlW@a(5J5Q"R!qLuIMKC^!+OaY5JoFDaZ\72FID9QQ?ad^NL>j,,]d,Yko(i(-s]"G.`N1O+c>WBTiB4I3lf,-L%:VhpXi!lY,]%W69Rt7nLJAJ>&9Xl(O"3\>XJXVUp1cj7Rg`>Puo+cK4TTN>\BK*Q5(3b3P([cb@+e?UG!lTc<<YT9Is#%5MGs7R#_+!>UrTekHSqK`!s*Y5$c@D/VDXYF6usa/O!B0DQ^/&NGn:KCQ"1-38c8=J(]fYE]>@:mV?!V$7MX!$7MX!$7MX!$7MX!1+2TnLM`rP$2*[<.AL@5*1)eg.h85(GVsfj:pSTDoB^BIm\7uha<_>,qL`*#nRM[jVndrq9_RD:qfii?`p6[pV='E)4U$OoVtPa]E:Ee?BGfO:^u:'i6-i@m4TuiY#Ii)c(9R+&8^M;O2fkqO?&5o@;HRI`<J4b5-ZI@UhDtaC*Z+?8kD4&!88c(%W9GaD+tQN9]7/,.%jSMP3<5YGSoI"6=2#m+1u!Y$J#mAXZ[`RQ4j$7H4UqeC9Du2nrr?Y\C&\0I=oSJ7rrCBsT"\93^OJ6/a'QD[SpYYLW7SZjqNMT[][BB];?nNn`.P6Y0]2@1HGAFR)*`tl(g,YLaK;LK!N23u@P3,o@_RA);EF.IdEiB_a&9.l+>`9V[b#JQfOVIVA5M*%OAA!"cDaV!^CK!o,STLt>Z4,2*]Yku<`U1O5s-'nV<PFW5*p,a=MuDk[Z!]p%_rL%-f2L[j/.kqPGr5E4O^#HBX#!7SD]KP[ckj,a=:!_8grs0Yhj.V?C_3t?YWVbd7aJ@kFGIWN:9F%MR.5B"m*=#>>6*a82hfV\7K+6#iO;dIsYhg*>_5OJ-g'MPtRN4@uFmOmKc"YZ8+J%0V6hG.YU]l!!'e:[/a]d_IMPUrr=hrOoGE4dJj4:<O<$C";!l[&RGT*rr@e`+&Dj@YC3&DS5r$A/+DrF_qW#2l#P)eApDbp2J!4N`.2k^!@Q>2TCEQ7<ReY^XP)g=7JsUT+<=a.2lQI^g]uECYJ^A?&H"9BNsj"dIi$cjPB@:#dQ&S3GtB3_`F4ijV[#=*#!2@5!;F_"U:IgdcItp\WT/R9PdHUriDfmC8N[#YVi/83l$`rRd]IXbH_t(;MFTKQXJpfEQ5S!fJ`%Haf">@*XE[7S$fZXACA,5-Obm3f!?U>?L)DuO'jqO\HQ;aP%nF(=K(@VWRq\Xd#uj$-`5._goH9/"W@Q3Aa5.m,:W&_.;R=cY&Y[u5QNG/=RNoqljnbK%a="a1G/miW][Eq@[uu7.(nP9$2H$fSKdE4[T/qO^o#'cY(G0c(55O:$hU;8Sid4_ZE>2<OZn9T6!QpuE?V540X6H'D7auQ"9/.S5%E-F2lug>-1Y0&H"mXqUMo=I/\^U3JXZH%$<g-RUjhX8`T5e*j^rU$?YM_FeLjh+G`P2Y#4\"<uRN3U3GiQ0AGsaZ0Q#b0#I#:I+#B;aDJWWKO:MY]0DIAKL,tVO-6_oOSQ'ChF,H.RlbTZNDT7K0GGX?gK:VNFSk>/RG:Mp`D5Er&TQ5I]br!dk0X+@A+But3;L>iHJo8or32,^43k<,%I^cB7'VSm2r?>4cVK$ldtI=B(,Hef=_qs7B_H/^iL\AP+RE6<2UQ;c+%oK+#5FWE["qUpcmE>$G6&WEaj62Z]B;1B:)IQOF7I<S@hQ%(BZCUh9;c8Ls5F.P*iUjrb!!-bUSptanQeun[/>1m$6kk]FlfNdLUdbKWBl%NsI$>Zil4B1/ophut0ErQ-;l>/<SU8O5*&"_GrFI:UH:TLCq*<>GC4ADL+gnhEM\#.s95'B@(dQ9>k:&m::!c$9bVl/cUXP/C$[@BqF<UM/8e=O/QOj=6E8+q7g'3apXWiE)@$E+'"h(JiC?cV'p:HV5K!+<F2r=maE&9TVZpmXO^\6F;SF%r6=3*>1PNS+103NZQ<L\qk52")(T,h03W:=^qO-.F7DH@et\UB-UNN&/9b5JTJsC,_7>^)PR>*oV4X^Lh[M.[_bb5(J3F9Td[/G1OHU9b^Gq!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!jMSmip@Dr<q4u2G>_V\,6V.<['D=ES.)-R%gR_kQ/pi08,SQq5O9U2rdc@B1j1U$7.@RUA27mqCE;F&[[-X8CM;iIa=?bTWSiel\?;R=Vo0Kb^8^ug>9r0K#)R2<)\=d-OfJn:'8!tg2:$M?a1CDsn-J>V$[JVsm_6[Eg,&QPQ9_r'QQ(=f47JW7pM7890X\37cZcCXQD\;hl-no9NQcRsO=ocDOPhPOq3-=6;Fgl!cO4u]`nhiMd-mm[2!@%bI:O[r@4<uWmGN]S_R!_S%J$$P%g(A%57;3I0CUjESYaIEod!,g7W"ktVsY5Q3QTMa"$#QNTIiksnXbjGQ>(NOen4VTL=k;79,NrLJ>ro\!cu`Hp#C[/mbnbJk6`tfJkt;0-G2:Th\YBipq/9M+%g<1[@/XPZ5CB"ARoKdo_F_0p%`oQ#;tq6!R"UC7I[ITi_T>>D7)8_[eGjLdTXm5%%rn(A-7>mHJ$gAbr<P/9Y.+'E\6Y:^j.goj!Oq_"J3;\GXo_Y)Wsb/+!,-+D:OBC4B!pO!u&:9a4i\?kH<n]gA&9^\+,N1oaOC:k-28@-+hHDMhtnS<65%a6RL`@kFrl\rQ]?I\C1,^J$&']INJ#KOlEDdH_Xh=EGN(_Q*$mB8KDbU7XkctY9s$=W6M,c$V`tE_JAu7rm<!7YRd=+%bOXpr^Z0u;GZg=?IH7=#MNohC$mkP<M%D#dTbM[DIl,GFH)EK4]QR-o^-L2@T1_<X\iD9ikL:qkD+L6l(/d$e*Sfj[29ZMPUe#QgNnQ,\;e+^'&.Y/GU.>O]Ag#MrZ1Jkm^]913[3B_h@u+i_n*Odg(m[49TPR2K?asG\E.hBqUkHZMW/`c[s=b^'L@m,NMLL/<"aZ]>^hgpD,Xchr%3,j?"pSb9c@f`p1O1G;=bJCB*DPAB0#([gBY)K%1QDTV`E_^*r'ZmZcru6I3mo@O#2bdO]+9[=c`ZS*rW.8Y6=fm5LoP(rVLO3X'XD\l8*,m(&">>@5[uVn?e>3^cm$G%MWl3Onp,`4U5h?BMi)/5K(fn9%SG4BrOCr\FBYNcXlfa/adGa18*I77``amAQLr(:=o0b*I*@Wrr<aTT+9aKVC%;&83Y@Hj@EV\j3'YN2t#D1kVoPP[/rKDMWEmNFk]mc-3!ttiRBE#mE&pXB`kI21'J(UmE>h=lm+3(Xh`\DaNsB4?IH7=#MNohC$n)Kb-TcLRS/!s/^1.PDNV4[`u.n&_pbh#6e83>2";rRHqU=6;R#YNR:iAP-D>0eKr<fGN8dXG_2'3NbAb!:NkEkJ$M!kI]N_1VT%mK5M6CU`m"e,k@$plE>SdMU@puu6`""cg?V?*6:nkV/_ESX?NtlmY:t6-AOR"h!8Sj])g%L2A'a&pV3-J[gE#/u"`H3$MLpcP%&aA!`(9&3FB\+&(gpSt0B+[tYW<,NApIWJJN2XS<6NaZh\1`QM5Ip=8RA_(jH[)_F/j-%Y;LGHCkA)\A,GFOP*r$cC!-iG#qe\\"!9129oc#J%=1Y`eAVf/:#+[QMm@/+3$hJ<n`bSB0(5o8A;81I8XYRoab=8q)bBJGa"$t3d!_2*.+E%/i#pYNlY?mrR4D3Z>NGq!Oi$^G,,>bqUdO#0>D.P9?'LC^\,ufN62][/;($L*%f/6hI_DCJ'*g84QHo?7Ni\i1H+Cq/@N\e`rrAh$DM?(rNAs6<crN+_,M7/T8fii_o3AHh,R1;`'Oj^noiEq,C*t*=W`%-)\NAB)ONB0#[>dFA0XWQqH.[_?\4'/Q35]f!S*Vc,B*ZQ)"p()qTe]l@abE"5X]X/OTmm;*5*X4V/[erjn>PO]*>)&#W#FBW@5Y02?lE0^f!W4HId@*=G^VR)^C478oLcWnF0$Cn)5p441$G.9f+2mO5T&?fKD!M!GfBdr/ko(kGLShZ2/tsq=W%,7.Rk;YK\hFpG*_t[TI_QT(_!j?m^PhfFrr@_FkdoM^bJCba.cH0\HMN&4-KF];d_.O9>s7q=[!a`(dWL&Fbp89oH#]_-"Ato3j]=2enm!iWDY;UjQ@M*7f>`7qe9jK_gr\MJX%V1f7bqo5eJVQU'/G>JYik'VQQIh!4CY7:8^TAu*-c_9LPN8Jpdnbd96YeF=BuEp(eGlIRmQQ(YohdLN;DcQ:^;f(6dYKc[4d:nWFMml@n/9P]&MSl=dK-*$PKI[:<#9Zq:BWV;('*QA#`bd=l*Fh>pO+m2YPGe&m\9_#"ASQc8#!pif](q,L(TniM5BSJado";7=!ASZQ'29;imYMGV9S[]fmbgJ8e/A(IRQ8#5H3ItSr2`$m0B5`KI\;?kqs#jmS'glcu&<Fb[)7&6Id$1PBWWaBOK'.ohNe85E"Z\o-mXJLe72`/#jR6Vj>HLoBXBQ\ss#(Hn#%I8Mtp=!l'Ko;3Hp5_"U[P5Uh@<-T?)gSW\BZ2+)kH]>+pnQc<Ne)Cln6R`8$HBEG7Z-1^(sYT@bV4I%or%^6ZdiOS23mm@$XZI,_\09BA[dW&M,1,4NdHKul!%I;n@e7rXQd<MT87Em_.k5e@=n_27i4?%JA\])f^u>$h?^58U:5[VE5[;>'QC&V!$?nK5'#3tnMc=&%H8U^iI,/e;6Q-RX^SLigW(1?Q:(]j,U[cu__s6j)6\,N:mHD=TuT='p<uNA$uZjD;:Up5O?r-PXmAnM*0aC<HfM57epA@u[^jk[[4a+j_AN\D_0+U9Bc)!U3'$"Vb'Yr59uheP]L?n?rMf2C\nEWl@sJB:m3Y7i#:5.k%L4%XoWMDlJ35dKKpJX2l[C/Zda>I,1OR:;`o>!?eb5C;)iF#i]K22+\cLf?&9s]'O,:W[Hng,K?HX)&V6.C2P=X-iN:$F-QL4ci"Xhcloc-hd*h[b=_J?hd_I!iBlmM;b[edntaXt3$C%B9IR*[9;15&MdF-E1V*])2k+8C84i8$HjpK/mCX/N=l,=W(c6';6nK#Fq>1,p$5Zr(cL.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!o=p4_):j1DiJ;T(*m;cl>c#>2,cHM!<uC#]4HA(gY=,+84M+J[a,9QILDjfX'%5B*N@h:"n#pB6&fn62aGCQj,d)T*]Q)gQD\RR`Sf`V-n:c+)gtYGJZ0"\'THm&RB4=YW%g1G1=*Y"ZUtj4;%DJ`O/@Ls*.36:36]^\dIU8T1r=<8&,G+DDQDLJR'2I#J"G9UYYY/r@Y[fL5"U?MQb"2Bg\P4^.i`uI"dj<P1an=t:@*OO=6pkbO16BL07S`(J!0NNoTs%.aNjfLa4P.V;):Uhpf\#G0pjPpk_fE%SW*N%(q/PHX=M2+T@X-j`NWD9HH92cS/5eBHX26;'Cj$[=BBj4':^7uO'`.h0L,HXL>14PD)sM5Y3=M%k!-]uRJ9Z2^*-B?r22Q&*HgLpnbha&_m$?g6]sa&@*@+$K3^N?n0d@eL.)7*^*@oL1e80#@DChHo\!H=6Dk@)'XRTqc\O"C$[VF>>Y,jJHmWhlgHo^4?%t#M4nF`'P>3jQeNGUnMN>lb_O:H:QBj`\NS/g-6ESqoWa_ft*[.*IWh<>`XF*O>2.ahQm?8cM/E\Wk7o7H/'VCUP;WkPqhg0!q7&pRKr(]OIPF<;4OC!.fWSSYQ)"R$_mpOql9N.L+$\BYP0-E6s9/X'<%;F%Hn")I#@iI(%NJqH3X);oR;CDXoQ(".J+Q=EjJ<bj^Kp@:R,`::A*)+Z"P!3JnjLXtW7n:SS:*Z*5s,eCU7Q2>[M=llrg$9;@i,NUJmM$&Ba2<ZtSaUPl('tfkC3^jo_>Oc/-lUu)3%@sS$f("RTM#p/!U8Sn1V4iJ#IgJ4ZifAlp!8?b<B]@rW(lB8JW6X4go:<gLG^`Z@?UNl@6H@&(2YP_uD="^X_5'IO7"b_V1,3ZtfJafN_Xkc_\\,S_e*SEm]t&mOg+eq_B`]K=S<Laf+dsp;,G#2S=Cb7m+u!S>,9VS!Jih?P"2Sk;"63N9HkUUn*OK%a,5&*W(]-X)98O%rm4>D01>Z@t/p_hQ]Dhkgh?g^^[tGA539(pjUoQA^c2buFf5\hJkI2ok^8eB8fZ0r2VnMK/hT1F>[V8]3auZb3jGja-D@8f>>10gZ5DSu:DhbD/lRN/`Sl-9E+ZY\VcoYgaH>[WNjYn4]nZ8%j$+`nBg+D0DI+L<8rM6PA`.d5pQ<,:KD_IUs4ZtN+qaDNC(=L6klM_RNY<FjXIOe%p3c0kSg#XE"gfUYNPm!%rAK>`74ERO9)>IiEn8>/`bsu,q)bWj"L!iY4&?KWK+ZmtoiPEi8%lNT1\(7!bUYXh`6#1<Y2pFI9&TVhGa+;>7nYe=I)T0KS4jK=l_<9M,-s7eM=#_=_7jA-=penN.)<]isn2Sn21$a/)XiL?3AqE+pMDdOj`1,AM`rjP(@4Kd`0@@F>W-h4amk!fJe@[_U*r!(6kX-!/o3pE_M\XAG6FJVg%S_-c-A>meh)-`?ka`l%F!Q_i2?6U?@S+G:W:UDshuR"\qcf`*h"&dE?4cWKKQRe;a/mr[*PL:EOrK(E2jcmKLb_<TkN3nI"qOSrFAY:C'UREX.eo"%pj??%>A5!$&O"Rs8n*.8jVsF#;n*rTn-I/%Oi;.OL0iV?d]^%4lc<r$Q-Ij[h+7'.L*oeaYrH.1:Da>,jFN>78ETDS`4]M`]7t#V4`1Oa[nsre/LH<tJKS3ZKOjPk!B<()?&Vt#Y,m@@0&U!1Lk!jGq4_1$aDpd7T"sE2`@c[;\ad[tBVp&c\/#Hlp1Ml;LAO#']5A#:(u=cOqk3FRBlCY$Uf_Au)IkAk\'RG7L:;cW=*IBn7_fi&kIAUkjGNQB+IG>&hfp(9c;ERLijcBh(5S9ESjk.YBCA?V"Nf"uP!sK((6s6Dr()AdMWS$Cr%W,'f7k+4jHUuN)tAO4+QGKEQlR.f0[_TG>ru&mQ:mT&(\6r+(s.&1$qc*'NK'Id%AtP9Ii7JDQ481cpK"Mpd'RjGUq'W'0F/#)1;F)V*:QKASd.U2/<f%AKk96EWp'&lHZ:T<EML?%S,'?$lq723<U`Wj^Ge<U4^Mu?pYf_gg4Z*PIq$qOGd$N%8fQN,OsVu%!tBgkDI8W]a<V1U%o7%\9p8n%&"23f-J7,L?<aRAh7%?NA#[KR2<O`gMjM:&%pnMfmdB2'=Lko"LuadL2[+6g!U($r3Ffkt)A[Y4^8LLacVq3*nk0k54ls^Kfd$pDXoS[eEiO)-@K8U"JU)*TDt&MOkH_aNgM=go<0l@fKO8I)]I=^K["FM0k\5NRL`V\"j"3%AW[rAC:2QHeXjYWdR3>M9]-@<nO?`qZp'-]?a#X[B3_[QU=,U,5Cue67$H\B#k84F+meuThjgCXs/+4@pB.OkME*hdS[?BCgf&le;\*hIkG=IHJ^>,D$ZG[0/`R#N-h['-;(=lR8$Tn"t%(;>dM\3O`:>B^0J\.gdGW9)T'7<0q'1(1A38i:,[&f1T7^J4)6aq*%68GQ24,s:]EE^'mf*@,E4(kMf;T0od,>,7GaUm<*1"mTKbKgSP&#l]J:t'@E^\G"@_X+DlKM-(:6fR$^<`0Lh%!Q^2H*4cp3fFuDJb4/qo6/)e$nPqGUWY3')]O=K#9tIPK?k54bh^qkc])u01?pp3=?_H4df__.`(DBJp20n9A*)_QO(r<Yr+.,lGDT[/e0VcUoW:sD=^SK1O#iT\WK\JdA?R+s\u!0gi7<?8[(;QZDfitF6lp3qM38B/9tp^s9((D]I7L\[Gj]gh1Z6oO_b7FB,eA[T.;0ue`\RF[E=`s50p0Kb60B(-)@+:Y=L?Xi0j]d/*EB9/`OdtL(hIZ]+G)\-J^fc3M")RDiUI/.4;"\1\?tibb6GIZA!SOYCq0PU!_!4o\7BU1N?!e&>N7+`QW1M47nA35k.?41dsg^]>NS`r(>oTL-glpnG\!.Apj_f(3t!#'rrBCu>6/bFdSJ]p6'aid?A_2[FO(iG2urSV+3$?2ZR2Ra00Qt:@395WfH/kD;@>":i"2[cEcK&gDrY[Uip+AbCPWd(rrA)tkI5-b\N%kLLu=EB2@8c>j1ImUlC,`'j3(('H^LVBdOh2F@gai/3q"X=\H,8FJt@55Z)I>2J`C)GG[F+mA"#PahYu)!W'%Lk2"*"kp6-V8a!#M`ghk:A)6r/TQu"r/HpO4`j3+j=2K$htKWJnK(LrVQ)(^7UkcHsQVHrJ1\pFgcC%!9%g&7f(UDGBa:;TLt3@]"#k8!0/-LgH.XLH.&CC;YHP4S#NC=5MkQNAF1lAS1Lr2"Z+7XEY*ZZ-M9hngU1NJ5WCWt"ae8JtR78Ac7(?9Uk,$5E0u3!=d73igREB_F/f>Y?l\St@ZuH$'g4j+:'nj_Ss.gpu,E>k<mmX`^[hHLJf/*D;dfrrBGQ1VT@@gW^KfN$KZ&"7CfZF3#JE%<8?^W4)5^MW\-LZIJP==n_'G2\#on',?Zf.>G[l_(#^<3Pa=t!bsnSpjIXf_`c;5!5.,ME4JN(_6H@tI&B)8Y]:$7-jFdg`L;.t&L4o4>3kNjEgH'$1N1oIG@2@7EPgdE&pUMH%s[6o?h#2<V8m.q!4.nW)p;kLmlP_JAh1;RfF1&/Hf/q`L7R<CH$h3C>n_@\&%D=Wng8JddX:Z+#i-DN9UilN:-%O9?c%"/@ebf?%6eGQ'AQm4EuFP<B9Zg)53ubs"Ei":E,Zp_!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!keEN[o2Kt0(>ckbc`%AX!I8n#g!9QU.sKA5M^3EHWQll+lc?.?f1,e-]#-0MG7;DRGL#N?XheYlaB@YA*%/\1#O+[])e\1GXG!Q]KUFoCou]S1rZL@5^ep<h.-U)_#o7IoK4%Ho>LAYC>+E1TkTF`h.`gKGU9lj'ha/%)BGrja;N#*1,?Yq]7!m\]L>68YAE<?b?_JZ,5!<oKX\0+H=UY5SZpR#?OQYt`&I4#QPtmPXSGp'f$[(&)3IOs0Qp]Uc9WE[LXr(okWQX+=j*Z*3e`<VGBFD!FnS6tW_!W62Go^2]F'eH(V\ffWNA:2(q/rhe[3G7/pohbgq^4s]?u_QAQW>OJEV;#outJ7m:T"snCW@bP31_Gkr"GfaIXufn(os^m("5oN]?i/CKbG`eZXlnF/[4>f=A9=,IJ<79.U6a6ui$?KPrj+PE!Hslfge3I/a3*^Yj_=]YEFNNX]o+&5On7NtS73`o]9uD`m7F"8G4t>W+V'A#9RnMGe]id54W.lJH'\2VRQB(9ib#kal.m=D+N:3$tpn45jt75?bfr.aIo^nGUUaUY&krY)@>F_aL3QBE5L/5WK\,35QRmMC%b9K/B@^S!9C/eL]jnc-.9B8@N0*q=$j<]N:6rcQk)lYF$8CG:o<R)oicGeq3$tFLsP$42Q8r#s,?Ue#tkDLS\5&]P"38i6;?&lUm=g7oh?5!iq$7h9`]U,:*m),k+P66VW>,e`QDBMQUL<k(:cSe)IgF\TqX6=V\cqLFbH73:(rl4e8L/D7g\DI5L.(WGc27_5UVSG7m\jMM,OX3$)Dn]P[n`"9mkbhU[2-XE*1`qU$8.nH%S;cG-@6B[R:5%VLO]dQ,jBOJ.:XKFFgg3SG!M.b1_]kEEiMH;37Q4fW64O)\YaR97[0!pW_Z3+,3O3TgX)j(7`*]a'=?Fem[b=N$Z0JZN@5GS2^4)D45C!uO&cSt!=C5s9t1F5p%#l2sDb93ja8i[_K`T`*9#&Oumh>6RcAT"J[7H1kU/-2DicBXcn1&o,-*9k%s/a?UouVmfB`L02B@=((Gl"I"cW:JR17nTl-7-Lb9,O[ARK&DO"8<<RS[4+Y`IS.(Hnf'im7X(]uJp,DhX_[O,Yc/^fQ<%BFh^o#Hb3Q=Y3(uqbo+o$nkCDsV\!/8F\Uec1UT<#eXE?\$_!/OB8%cEZ9diS0c?9^*i,M)j+5DT6^4tL$tpeiCZ(gSq7r0D>bCG!u>a-V@bS1`T^c[P#f*Ab`W?>>oC(KrUug?[,-2OuP3hW,l!`2U*H-$^>>Y+&9Inn<5[:0!3LCM,QbC_2cs4*P0Z!O86(jq\jN^\tFqh.C"&>`D(hVG0tJip%;JBc[nVbAScN%)d_I7RF"<B'a*N]M#:"K>Cn,<r0_UMTfG]7RW-N0UD%qS8q1IRlrrOB8Y(*[u2WAO2;eUerMXGg6S+Xde(\[FHOEXK-98A;34AkoG'Z6?%1Bopjo3;LHNh^gtl:>>U8flOA-@^O.!fe&4sqC!-oplfM*`!(Olr8k]^6QGZesGSHnS>K?F2oSt@r(nX_o=UqRCeRb+,kROpT#!*QSST(bY%jH2'4(>paF,<1hFN/Tfs$jeK"FPn2r:Jea5e@m2Q)ZJ/^/[`iWoW^qOM&@K[r^O6$XV8Vk%tjQD#E:''aQ73)o\7IJN'u&fP!%RG(_pY"g`ALh]r4%HW9G?Gn4gU0K_JZ!O/L6:F*Nj;TJVOaSZLeTPU,0.UD]sGhtk\t?,*L=HKX8oO%,>OG5=S]phhN`,eT.Wk7q&HAQZD=d=MljJ\WXN.p?j)XSUF-7Ze*\QZ?2f6ZeM/U@MHqW=0Mu,j,7M#:+;\2bDAD7ATi>e3"#j6dI2SM`Y31ArK#$;\m<To5@O=c<"^E.)p>H\%6/=Q/YFEI1&fa]6u>%L;lm"52tBEgUQ6'(4VF)+CU=uDES"<#H;nH!9,<+h[f1g7jj%p-*`$>9a09<"HV\jA7.3T'u1&)SqI2MpYI1*9m5PfdkpjgDJ^uRk2@BF6H'qK;&J#2\&`WRW\V=J4E8(Xd][dhKpn'VZsO5K>$hMjMb3=[@RElP)%<*F;j+>UGA">i26#U6'R55h8S7J3U\=I7_eIi$Ku?ha$^Erg/`m*ga5&phodS]+=dErQ<NH]PBf\(s8J]e>cZ^KeW-3!M`XX[=EU1^oTZ94'H1U9L-+!,;L,E\HNi@"6OS1W=`@=?V3uH9:gd0R`Cm>.n_O^pW%6sV3$7MX!$rMm1TEN'*'N%+'MG+@*TE>n8;*Y=6`=u,M@Z4/Q!#VIF;*Y<h/JM"_?r;e0TE>m;MC8Rd[.&7FVTp@6r+2fmV=/X*1YTYrTXtt!Q'@l9rSY`Q]":$`Ci*),!(&;5=QH_7-&M%],a7#I72,bd.)cls!msFN!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!*0:'!/#B16WTORA@o:aR8kT*b4]U_PV3EZb@TL\`_SRgM?)/T[*)/ngW6a\Wg;H,m`tA]!8Pl<ZQ&s#8N6h#XjKQ;'N%:!'N%:!J,e1~>
endstream
endobj
16 0 obj
<<
/Encoding /WinAnsiEncoding
/Type /Font
/Name /F2
/BaseFont /Helvetica-Bold
/Subtype /Type1
>>
endobj
17 0 obj
<<
/Encoding /WinAnsiEncoding
/Type /Font
/Name /F3
/BaseFont /Times-Roman
/Subtype /Type1
>>
endobj
18 0 obj
<<
/Encoding /WinAnsiEncoding
/Type /Font
/Name /F1
/BaseFont /Helvetica
/Subtype /Type1
>>
endobj
19 0 obj
<<
/Length 10155
>>
stream
q
1 0 0 1 0 0 cm
BT
/F1 12 Tf
14.40000 TL
ET
q
q
1 0 0 1 30 836.63980 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 2.62500 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
Q
Q
q
Q
Q
q
1 0 0 1 30 716.84190 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 0 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 0 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 17.52393 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Client) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 64.20000 17.52393 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(\072 ) Tj
/F2 9 Tf
(S\056R Medical Center) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 428 15.50000 cm
q
1 0 0 1 0 -1 cm
q
q
1 0 0 1 0 0 cm
q
[ ] 0 d
BT
/F3 10 Tf
12 TL
ET
1 w
0 0 0 RG
1 0 0 1 0 0 cm
0 j
BT
/F3 10 Tf
12 TL
ET
0 0 0 rg
0 J
q
1 0 0 1 0 7.54785 cm
q
1 0 0 1 0 0 cm
q
[ ] 0 d
0.00010 w
0 j
0 J
n
0 0 115 10 re
n
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
18 0 2 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
21 0 1 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
24 0 3 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
29 0 4 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
35 0 1 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
38 0 1 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
40 0 2 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
44 0 2 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
47 0 2 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
51 0 1 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
53 0 4 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
58 0 3 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
62 0 3 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
67 0 1 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
69 0 2 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
73 0 1 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
75 0 1 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
78 0 4 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
84 0 2 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
89 0 3 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
93 0 1 10 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
95 0 2 10 re
f*
Q
q
BT
/F1 7.79528 Tf
9.35433 TL
ET
BT
/F1 7.79528 Tf
9.35433 TL
ET
0 0 0 rg
BT
1 0 0 1 46.66457 -5.98880 Tm
(88019) Tj
T*
ET
Q
Q
Q
Q
Q
0.84375 w
BT
1 0 0 1 0 9.54785 Tm
19.79785 TL
115 0 Td
/F1 9 Tf
10.80000 TL
T*
-115 0 Td
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 0 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Patient Name) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 64.20000 0 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(\072 ) Tj
/F2 9 Tf
(Mr\056 J JAGADEESH) Tj
T*
ET
Q
Q
q
Q
Q
q
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 30 654.84190 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 0 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 0 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 46.50000 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Age\057Gender) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 64.20000 46.50000 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(\072 31 years \057 Male) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 31 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Phone) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 64.20000 31 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(\072) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 15.50000 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Ref\056 Dr\056) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 64.20000 15.50000 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(\072 SRI SATYA SAI LAB) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 0 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Req\056 No) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 64.20000 0 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F2 9 Tf
0 0 0 rg
(\072 252105545309) Tj
T*
ET
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 321 0 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 46.50000 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Sample Type) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 74.90000 46.50000 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(\072 Plasma \055 PT) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 31 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Registered On) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 74.90000 31 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(\072 20 May 2021 04\07215 PM) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 15.50000 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Collected On) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 74.90000 15.50000 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(\072 20 May 2021 04\07215 PM) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 0 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Reported On) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 74.90000 0 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(\072 20 May 2021 06\07214 PM) Tj
T*
ET
Q
Q
q
Q
Q
q
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 30 653.84190 cm
q
1 w
1 J
0 0 0 RG
n
0 0 m
535 0 l
S
Q
Q
q
1 0 0 1 30 632.26190 cm
q
1 0 0 1 1 -1 cm
q
0.91125 w
BT
1 0 0 1 0 9.60104 Tm
240.57190 0 Td
14.58000 TL
/F1 9.72000 Tf
0 0 0 rg
(Hematology) Tj
T*
-240.57190 0 Td
ET
Q
Q
q
Q
Q
q
1 0 0 1 30 613.64340 cm
q
1 0 0 1 1 -1 cm
q
1.03866 w
BT
1 0 0 1 0 10.66378 Tm
244.95690 0 Td
16.61850 TL
/F2 11.07900 Tf
0 0 0 rg
(D\055Dimer) Tj
T*
-244.95690 0 Td
ET
Q
Q
q
Q
Q
q
1 0 0 1 30 596.14340 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 0 cm
q
1 0 0 1 0 -2 cm
q
0.84375 w
BT
1 0 0 1 0 9.03800 Tm
70.86850 0 Td
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Test Name) Tj
T*
-70.86850 0 Td
ET
Q
Q
q
Q
Q
q
1 0 0 1 187.25000 0 cm
q
1 0 0 1 0 -2 cm
q
0.84375 w
BT
1 0 0 1 0 9.03800 Tm
16.98250 0 Td
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Observed Values) Tj
T*
-16.98250 0 Td
ET
Q
Q
q
Q
Q
q
1 0 0 1 294.25000 0 cm
q
1 0 0 1 0 -2 cm
q
0.84375 w
BT
1 0 0 1 0 9.03800 Tm
28.87500 0 Td
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Units) Tj
T*
-28.87500 0 Td
ET
Q
Q
q
Q
Q
q
1 0 0 1 374.50000 0 cm
q
1 0 0 1 0 -2 cm
q
0.84375 w
BT
1 0 0 1 0 9.03800 Tm
15.97650 0 Td
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Biological Reference Intervals) Tj
T*
-15.97650 0 Td
ET
Q
Q
q
Q
Q
q
2 J
1 j
0 0 0 RG
0.80000 w
n
0 17.50000 m
535 17.50000 l
S
n
0 0 m
0 17.50000 l
S
n
535 0 m
535 17.50000 l
S
n
0 0 m
535 0 l
S
n
0 17.50000 m
535 17.50000 l
S
n
0 0 m
0 17.50000 l
S
n
535 0 m
535 17.50000 l
S
n
0 0 m
535 0 l
S
n
0 17.50000 m
187.25000 17.50000 l
S
n
0 0 m
0 17.50000 l
S
n
187.25000 0 m
187.25000 17.50000 l
S
n
0 0 m
187.25000 0 l
S
n
187.25000 17.50000 m
294.25000 17.50000 l
S
n
187.25000 0 m
187.25000 17.50000 l
S
n
294.25000 0 m
294.25000 17.50000 l
S
n
187.25000 0 m
294.25000 0 l
S
n
294.25000 17.50000 m
374.50000 17.50000 l
S
n
294.25000 0 m
294.25000 17.50000 l
S
n
374.50000 0 m
374.50000 17.50000 l
S
n
294.25000 0 m
374.50000 0 l
S
n
374.50000 17.50000 m
535 17.50000 l
S
n
374.50000 0 m
374.50000 17.50000 l
S
n
535 0 m
535 17.50000 l
S
n
374.50000 0 m
535 0 l
S
Q
Q
Q
q
1 0 0 1 30 549.88980 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 13.50000 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 5 7.03800 Tm
13.50000 TL
/F2 9 Tf
0 0 0 rg
(D\055Dimer) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 3 cm
q
1 0 0 1 0 0 cm
q
0.65625 w
BT
1 0 0 1 5 5.47400 Tm
10.50000 TL
/F1 7 Tf
0 0 0 rg
(\050Method \072 Immunoturbidimetric\051) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 187.25000 13.50000 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 20 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(0\0563) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 294.25000 13.50000 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 5 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
/F4 9 Tf
13.50000 TL
(m) Tj
/F1 9 Tf
13.50000 TL
(g FEU\057mL) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 376.50000 13.50000 cm
q
1 0 0 1 2 0 cm
q
0.84375 w
BT
1 0 0 1 5 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(\074 0\05650) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 376.50000 -0 cm
q
1 0 0 1 2 0 cm
q
0.84375 w
BT
1 0 0 1 5 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
( ) Tj
T*
ET
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 30 518.88980 cm
q
1 0 0 1 2 -2 cm
q
0.84375 w
0.84375 w
BT
1 0 0 1 0 24.53800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
( ) Tj
T*
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 30 501.38980 cm
q
1 0 0 1 2 -2 cm
q
0.84375 w
BT
1 0 0 1 0 11.03800 Tm
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Interpretation\072) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 30 456.88980 cm
q
1 0 0 1 2 -2 cm
q
0.84375 w
0.84375 w
0.84375 w
BT
1 0 0 1 0 38.03800 Tm
1.31347 Tw
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Elevation of D\055Dimer can occur in variety of clinical conditions associated with fibrin breakdown including Deep vein Thrombosis) Tj
T*
0 Tw
1.20407 Tw
(\050DVT\051\054 Pulmonary Embolism \050PE\051 and Disseminated Intravascular coagulation\050DIC\051\056D\055Dimer is mainly used to exclude the above) Tj
T*
0 Tw
(conditions\056) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 30 439.38980 cm
q
1 0 0 1 2 -2 cm
q
0.84375 w
BT
1 0 0 1 0 11.03800 Tm
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Note\072) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 30 408.38980 cm
q
1 0 0 1 2 -2 cm
q
0.84375 w
0.84375 w
BT
1 0 0 1 0 24.53800 Tm
0.98905 Tw
13.50000 TL
/F1 9 Tf
0 0 0 rg
(The result given pertains to the sample received and depends on quality of sample\056 D\055Dimer results vary on different instruments) Tj
T*
0 Tw
(depending on methodology\056 Hence results cannot be compared with results from other laboratories\056) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 30 392.88980 cm
q
1 0 0 1 1 -1 cm
q
0.84375 w
BT
1 0 0 1 0 9.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 30 367.38980 cm
q
1 0 0 1 1 -11 cm
q
0.84375 w
BT
1 0 0 1 0 19.03800 Tm
231.73300 0 Td
13.50000 TL
/F1 9 Tf
0 0 0 rg
(\052\052End of Report\052\052) Tj
T*
-231.73300 0 Td
ET
Q
Q
q
Q
Q
q
1 0 0 1 30 290.97920 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 -0 cm
q
1 0 0 1 0 -3 cm
q
q
535 0 0 70.41057 0 3 cm
/FormXob.31b2a01266c0423b263008dda8a8282d Do
Q
0.84375 w
BT
1 0 0 1 0 34.60529 Tm
70.41057 TL
535 0 Td
/F1 9 Tf
10.80000 TL
T*
-535 0 Td
ET
Q
Q
q
Q
Q
q
Q
Q
Q
q
1 0 0 1 0 0 cm
BT
/F1 12 Tf
14.40000 TL
ET
BT
/F1 9 Tf
14.40000 TL
ET
BT
1 0 0 1 519 13 Tm
(Page 4 of 4) Tj
T*
ET
Q

endstream
endobj
20 0 obj
<<
/Filter [ /ASCII85Decode /DCTDecode ]
/Length 15157
/ColorSpace /DeviceRGB
/Type /XObject
/BitsPerComponent 8
/Height 117
/Width 889
/Subtype /Image
>>
stream
s4IA0!"_al8O`[\!<<*#!!*'"s4[N@!!ic5#6k>;#6tJ?#m^kH'FbHY$Odmc'+Yct)BU"@)B9_>,VCGe+tOrY*%3`p/2/e81c-:%3B]>W4>&EH1B6)/6NIK"#n.1M(_$ok1*IV\1,:U?1,:U?1,:U?1,:U?1,:U?1,:U?1,:U?1,:U?1,:U?1,:U?1,:U?1,:U?1,AmF!"fJ:FTZmk!?qLF&HMtG!WU(<*rl9A"T\W)!<E3$z!!!!"!WrQ/"pYD?$4HmP!4<@<!W`B*!X&T/"U"r.!!.KK!WrE*&Hrdj0gQ!W;.0\RE>10ZOeE%*6F"?A;UOtZ1LbBV#mqFa(`=5<-7:2j.Ps"@2`NfY6UX@47n?3D;cHat='/U/@q9._B4u!oF*)PJGBeCZK7nr5LPUeEP*;,qQC!u,R\HRQV5C/hWN*81['d?O\@K2f_o0O6a2lBFdaQ^rf%8R-g>V&OjQ5OekiqC&o(2MHp@n@XqZ"J6*ru?D!<E3%!<E3%!<<*"!!!!"!WrQ/"pYD?$4HmP!4<C=!W`?*"9Sc3"U"r.!<RHF!<N?8"9fr'"qj4!#@VTc+u4]T'LIqUZ,$_k1K*]W@WKj'(*k`q-1Mcg)&ahL-n-W'2E*TU3^Z;(7Rp!@8lJ\h<``C+>%;)SAnPdkC3+K>G'A1VH@gd&KnbA=M2II[Pa.Q$R$jD;USO``Vl6SpZEppG[^WcW]#)A'`Q#s>ai`&\eCE.%f\,!<j5f=akNM0qo(2MHp@n@XqZ#7L$j-M1!YGMH!'^JXqC&(g$7MX!$7MX!$7MX!$7MX!$7MX!$7P.-!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:)G?E7`fIA;k@W2=?#>n``plAM-]L-CGU"MpWPSJ'g2&io@hSm!aYpUW<JcdakXP7a!^I>0f0khOhm\MtN7;2kLlCW<T;K+eE-j&KF`G&X@D-OeIX[?[/<-E%c@)nPC+2Z^I$4$#1E1&]G(".>UmcsfP_g5VMnfhAp>"("-T6*.;/-iUTTFDefU4<S!Y&D<`p!/Di("6VJlB_O;hDJ$g!&DhiTH:T^MLn)R!#s9j>MU/c]^\YV5F3a`iO1oNg2YKtK9("N<\K-u6fIJBg$-g6P0U(<Slm"R4K_>f,k?Cr4`Yts>2#VNMC>,!MC>,!MC>,!MC>,!MC>,!MC>,!MC>,!MC>,!MC>,!MC>,!MC>,!MC>,!MC>,!MC>,!MC>,!MC>,#r$c<RJ-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-sHh#+on8Bh`G^d1a26iK]:s_Ln$cYQTYr@.;r^&4%MJCS$U(`YQ0WFaMammd;@1SRDee8BsdLbI;p#+9Dg[$D9<l!McIU9rV7-NGR2?&P19l$T?qK.Da`UL0m=3GlWGk$cQ08Y1[N<*P@ChP>Sh]0-Q1rMCmg38Npr>g/pidE'Mn`/#KYZ\'s_Bf$Y:j'[G3*l>fJh,a(_]P"@L\Z%Qk1W-m`NKjYjh.]O>pau^5?PM^-<mYV#)Ffu7pDfr%/V+E50,.UoK/cOba,K9o1-Z/!*jaG1Z"!!ldQ6%T`e9jb5NGiNZnjaq$j2;_i?S.CF,A/T[i+Enmc!8dUl^Q(e4.AmATU+BJqUeK!b0,FQFWg>>5.ksW4(7X-:"'QA[T]i="l6OTh/3kkEA/AE*&q?*O9bgf#iLSJCZmr7d_&"^QSsmUEQ`JNX<Qd_)bfIlM*Q>2BID;;JcPu`CO>A_\aJF.:%DI[+e<RAa!e(q4apI2a04()-MW#JXX_QN9l[.$'oP_(PFYH^c*B&W+BAn)V_,EM:NO=kLOf#\V"dR39++12G$=It8B'Z],s1VaH$3"a2]S>1U]k+]2t(7SBu3#9oZ!3g!b>>DAltj>:oXhLaJkF'+h;sMD)5P,Z-t@R6fL"a*FM1ECCi^YD%`!78uDiu_4,U%`OI3\j0iK"`oRZ:jCDm-LQ4AL]bRg;1I)p\S)W6qT2laU:;)r1@$8sq:YnU0.nZNOPNL\^/7lZu#3&)Q`7d_@U"$14]KmgjgN\#UO[dfn7l"pJ:?$9fUbS"bUHG':FQZB'D+SjpBaMLUr0=eE2h]:7F4V9Wo00Qm!!WE':^7/4nIZk^\rND3p9<2e!,)LDg3G"*Pu[,u.tS*\1)L)Fag%cA9%.oeD(>8-g2j1JalQc4amuR8L*h%1N:(.S/emti*CpFC^]uh:or<5iSsuM0q3SRV[ZTLP1J4p)N_`gYi\f&<<u)hoH0)BFdr/m1q`7G7PDJTMBhBr)(;c4J&$Q[e7R.h8kD)5DT+GAd::a0t3Z>pX`p`8WaObZGY.u6CTG?E]bWuI9V.OIgmZ6B[=$VX;:J<f2?->$-9.9BZ=Q=N-`pNk?;rs.arU-KeA,cN82O(GH6h\'caAMY8$0D?=mNKBDcj/<MJh,U!GV-<$;3kV/VO#@q&g.E[o0T$D!!!\Y9EI\s@9iSq@=)"08(I$]`8V3GC/`=%n[A"a..1koO9H=q5Qqj!5Qqj!5Qqj!5Qqj!5Qqj!5Qqj!5Qqj!5Qqj!5Qqj!5Qqj!5RGasr$c<RJ-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J2k58?EisCM[#*;>bSaYfj_S%%]q%i!JfAE5W<L@6cYdffg^83G*LAm/$jn*c&KpP-QP!<TE:!!TF*`OSL1*O8KOXPA[1ta[42QEl:WSA51i&P<>[hIVnh9BlW@a(5J5Q"R!qLuIMKC^!+OaY5JoFDaZ\72FID9QQ?ad^NL>j,,]d,Yko(i(-s]"G.`N1O+c>WBTiB4I3lf,-L%:VhpXi!lY,]%W69Rt7nLJAJ>&9Xl(O"3\>XJXVUp1cj7Rg`>Puo+cK4TTN>\BK*Q5(3b3P([cb@+e?UG!lTc<<YT9Is#%5MGs7R#_+!>UrTekHSqK`!s*Y5$c@D/VDXYF6usa/O!B0DQ^/&NGn:KCQ"1-38c8=J(]fYE]>@:mV?!V$7MX!$7MX!$7MX!$7MX!1+2TnLM`rP$2*[<.AL@5*1)eg.h85(GVsfj:pSTDoB^BIm\7uha<_>,qL`*#nRM[jVndrq9_RD:qfii?`p6[pV='E)4U$OoVtPa]E:Ee?BGfO:^u:'i6-i@m4TuiY#Ii)c(9R+&8^M;O2fkqO?&5o@;HRI`<J4b5-ZI@UhDtaC*Z+?8kD4&!88c(%W9GaD+tQN9]7/,.%jSMP3<5YGSoI"6=2#m+1u!Y$J#mAXZ[`RQ4j$7H4UqeC9Du2nrr?Y\C&\0I=oSJ7rrCBsT"\93^OJ6/a'QD[SpYYLW7SZjqNMT[][BB];?nNn`.P6Y0]2@1HGAFR)*`tl(g,YLaK;LK!N23u@P3,o@_RA);EF.IdEiB_a&9.l+>`9V[b#JQfOVIVA5M*%OAA!"cDaV!^CK!o,STLt>Z4,2*]Yku<`U1O5s-'nV<PFW5*p,a=MuDk[Z!]p%_rL%-f2L[j/.kqPGr5E4O^#HBX#!7SD]KP[ckj,a=:!_8grs0Yhj.V?C_3t?YWVbd7aJ@kFGIWN:9F%MR.5B"m*=#>>6*a82hfV\7K+6#iO;dIsYhg*>_5OJ-g'MPtRN4@uFmOmKc"YZ8+J%0V6hG.YU]l!!'e:[/a]d_IMPUrr=hrOoGE4dJj4:<O<$C";!l[&RGT*rr@e`+&Dj@YC3&DS5r$A/+DrF_qW#2l#P)eApDbp2J!4N`.2k^!@Q>2TCEQ7<ReY^XP)g=7JsUT+<=a.2lQI^g]uECYJ^A?&H"9BNsj"dIi$cjPB@:#dQ&S3GtB3_`F4ijV[#=*#!2@5!;F_"U:IgdcItp\WT/R9PdHUriDfmC8N[#YVi/83l$`rRd]IXbH_t(;MFTKQXJpfEQ5S!fJ`%Haf">@*XE[7S$fZXACA,5-Obm3f!?U>?L)DuO'jqO\HQ;aP%nF(=K(@VWRq\Xd#uj$-`5._goH9/"W@Q3Aa5.m,:W&_.;R=cY&Y[u5QNG/=RNoqljnbK%a="a1G/miW][Eq@[uu7.(nP9$2H$fSKdE4[T/qO^o#'cY(G0c(55O:$hU;8Sid4_ZE>2<OZn9T6!QpuE?V540X6H'D7auQ"9/.S5%E-F2lug>-1Y0&H"mXqUMo=I/\^U3JXZH%$<g-RUjhX8`T5e*j^rU$?YM_FeLjh+G`P2Y#4\"<uRN3U3GiQ0AGsaZ0Q#b0#I#:I+#B;aDJWWKO:MY]0DIAKL,tVO-6_oOSQ'ChF,H.RlbTZNDT7K0GGX?gK:VNFSk>/RG:Mp`D5Er&TQ5I]br!dk0X+@A+But3;L>iHJo8or32,^43k<,%I^cB7'VSm2r?>4cVK$ldtI=B(,Hef=_qs7B_H/^iL\AP+RE6<2UQ;c+%oK+#5FWE["qUpcmE>$G6&WEaj62Z]B;1B:)IQOF7I<S@hQ%(BZCUh9;c8Ls5F.P*iUjrb!!-bUSptanQeun[/>1m$6kk]FlfNdLUdbKWBl%NsI$>Zil4B1/ophut0ErQ-;l>/<SU8O5*&"_GrFI:UH:TLCq*<>GC4ADL+gnhEM\#.s95'B@(dQ9>k:&m::!c$9bVl/cUXP/C$[@BqF<UM/8e=O/QOj=6E8+q7g'3apXWiE)@$E+'"h(JiC?cV'p:HV5K!+<F2r=maE&9TVZpmXO^\6F;SF%r6=3*>1PNS+103NZQ<L\qk52")(T,h03W:=^qO-.F7DH@et\UB-UNN&/9b5JTJsC,_7>^)PR>*oV4X^Lh[M.[_bb5(J3F9Td[/G1OHU9b^Gq!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!jMSmip@Dr<q4u2G>_V\,6V.<['D=ES.)-R%gR_kQ/pi08,SQq5O9U2rdc@B1j1U$7.@RUA27mqCE;F&[[-X8CM;iIa=?bTWSiel\?;R=Vo0Kb^8^ug>9r0K#)R2<)\=d-OfJn:'8!tg2:$M?a1CDsn-J>V$[JVsm_6[Eg,&QPQ9_r'QQ(=f47JW7pM7890X\37cZcCXQD\;hl-no9NQcRsO=ocDOPhPOq3-=6;Fgl!cO4u]`nhiMd-mm[2!@%bI:O[r@4<uWmGN]S_R!_S%J$$P%g(A%57;3I0CUjESYaIEod!,g7W"ktVsY5Q3QTMa"$#QNTIiksnXbjGQ>(NOen4VTL=k;79,NrLJ>ro\!cu`Hp#C[/mbnbJk6`tfJkt;0-G2:Th\YBipq/9M+%g<1[@/XPZ5CB"ARoKdo_F_0p%`oQ#;tq6!R"UC7I[ITi_T>>D7)8_[eGjLdTXm5%%rn(A-7>mHJ$gAbr<P/9Y.+'E\6Y:^j.goj!Oq_"J3;\GXo_Y)Wsb/+!,-+D:OBC4B!pO!u&:9a4i\?kH<n]gA&9^\+,N1oaOC:k-28@-+hHDMhtnS<65%a6RL`@kFrl\rQ]?I\C1,^J$&']INJ#KOlEDdH_Xh=EGN(_Q*$mB8KDbU7XkctY9s$=W6M,c$V`tE_JAu7rm<!7YRd=+%bOXpr^Z0u;GZg=?IH7=#MNohC$mkP<M%D#dTbM[DIl,GFH)EK4]QR-o^-L2@T1_<X\iD9ikL:qkD+L6l(/d$e*Sfj[29ZMPUe#QgNnQ,\;e+^'&.Y/GU.>O]Ag#MrZ1Jkm^]913[3B_h@u+i_n*Odg(m[49TPR2K?asG\E.hBqUkHZMW/`c[s=b^'L@m,NMLL/<"aZ]>^hgpD,Xchr%3,j?"pSb9c@f`p1O1G;=bJCB*DPAB0#([gBY)K%1QDTV`E_^*r'ZmZcru6I3mo@O#2bdO]+9[=c`ZS*rW.8Y6=fm5LoP(rVLO3X'XD\l8*,m(&">>@5[uVn?e>3^cm$G%MWl3Onp,`4U5h?BMi)/5K(fn9%SG4BrOCr\FBYNcXlfa/adGa18*I77``amAQLr(:=o0b*I*@Wrr<aTT+9aKVC%;&83Y@Hj@EV\j3'YN2t#D1kVoPP[/rKDMWEmNFk]mc-3!ttiRBE#mE&pXB`kI21'J(UmE>h=lm+3(Xh`\DaNsB4?IH7=#MNohC$n)Kb-TcLRS/!s/^1.PDNV4[`u.n&_pbh#6e83>2";rRHqU=6;R#YNR:iAP-D>0eKr<fGN8dXG_2'3NbAb!:NkEkJ$M!kI]N_1VT%mK5M6CU`m"e,k@$plE>SdMU@puu6`""cg?V?*6:nkV/_ESX?NtlmY:t6-AOR"h!8Sj])g%L2A'a&pV3-J[gE#/u"`H3$MLpcP%&aA!`(9&3FB\+&(gpSt0B+[tYW<,NApIWJJN2XS<6NaZh\1`QM5Ip=8RA_(jH[)_F/j-%Y;LGHCkA)\A,GFOP*r$cC!-iG#qe\\"!9129oc#J%=1Y`eAVf/:#+[QMm@/+3$hJ<n`bSB0(5o8A;81I8XYRoab=8q)bBJGa"$t3d!_2*.+E%/i#pYNlY?mrR4D3Z>NGq!Oi$^G,,>bqUdO#0>D.P9?'LC^\,ufN62][/;($L*%f/6hI_DCJ'*g84QHo?7Ni\i1H+Cq/@N\e`rrAh$DM?(rNAs6<crN+_,M7/T8fii_o3AHh,R1;`'Oj^noiEq,C*t*=W`%-)\NAB)ONB0#[>dFA0XWQqH.[_?\4'/Q35]f!S*Vc,B*ZQ)"p()qTe]l@abE"5X]X/OTmm;*5*X4V/[erjn>PO]*>)&#W#FBW@5Y02?lE0^f!W4HId@*=G^VR)^C478oLcWnF0$Cn)5p441$G.9f+2mO5T&?fKD!M!GfBdr/ko(kGLShZ2/tsq=W%,7.Rk;YK\hFpG*_t[TI_QT(_!j?m^PhfFrr@_FkdoM^bJCba.cH0\HMN&4-KF];d_.O9>s7q=[!a`(dWL&Fbp89oH#]_-"Ato3j]=2enm!iWDY;UjQ@M*7f>`7qe9jK_gr\MJX%V1f7bqo5eJVQU'/G>JYik'VQQIh!4CY7:8^TAu*-c_9LPN8Jpdnbd96YeF=BuEp(eGlIRmQQ(YohdLN;DcQ:^;f(6dYKc[4d:nWFMml@n/9P]&MSl=dK-*$PKI[:<#9Zq:BWV;('*QA#`bd=l*Fh>pO+m2YPGe&m\9_#"ASQc8#!pif](q,L(TniM5BSJado";7=!ASZQ'29;imYMGV9S[]fmbgJ8e/A(IRQ8#5H3ItSr2`$m0B5`KI\;?kqs#jmS'glcu&<Fb[)7&6Id$1PBWWaBOK'.ohNe85E"Z\o-mXJLe72`/#jR6Vj>HLoBXBQ\ss#(Hn#%I8Mtp=!l'Ko;3Hp5_"U[P5Uh@<-T?)gSW\BZ2+)kH]>+pnQc<Ne)Cln6R`8$HBEG7Z-1^(sYT@bV4I%or%^6ZdiOS23mm@$XZI,_\09BA[dW&M,1,4NdHKul!%I;n@e7rXQd<MT87Em_.k5e@=n_27i4?%JA\])f^u>$h?^58U:5[VE5[;>'QC&V!$?nK5'#3tnMc=&%H8U^iI,/e;6Q-RX^SLigW(1?Q:(]j,U[cu__s6j)6\,N:mHD=TuT='p<uNA$uZjD;:Up5O?r-PXmAnM*0aC<HfM57epA@u[^jk[[4a+j_AN\D_0+U9Bc)!U3'$"Vb'Yr59uheP]L?n?rMf2C\nEWl@sJB:m3Y7i#:5.k%L4%XoWMDlJ35dKKpJX2l[C/Zda>I,1OR:;`o>!?eb5C;)iF#i]K22+\cLf?&9s]'O,:W[Hng,K?HX)&V6.C2P=X-iN:$F-QL4ci"Xhcloc-hd*h[b=_J?hd_I!iBlmM;b[edntaXt3$C%B9IR*[9;15&MdF-E1V*])2k+8C84i8$HjpK/mCX/N=l,=W(c6';6nK#Fq>1,p$5Zr(cL.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!o=p4_):j1DiJ;T(*m;cl>c#>2,cHM!<uC#]4HA(gY=,+84M+J[a,9QILDjfX'%5B*N@h:"n#pB6&fn62aGCQj,d)T*]Q)gQD\RR`Sf`V-n:c+)gtYGJZ0"\'THm&RB4=YW%g1G1=*Y"ZUtj4;%DJ`O/@Ls*.36:36]^\dIU8T1r=<8&,G+DDQDLJR'2I#J"G9UYYY/r@Y[fL5"U?MQb"2Bg\P4^.i`uI"dj<P1an=t:@*OO=6pkbO16BL07S`(J!0NNoTs%.aNjfLa4P.V;):Uhpf\#G0pjPpk_fE%SW*N%(q/PHX=M2+T@X-j`NWD9HH92cS/5eBHX26;'Cj$[=BBj4':^7uO'`.h0L,HXL>14PD)sM5Y3=M%k!-]uRJ9Z2^*-B?r22Q&*HgLpnbha&_m$?g6]sa&@*@+$K3^N?n0d@eL.)7*^*@oL1e80#@DChHo\!H=6Dk@)'XRTqc\O"C$[VF>>Y,jJHmWhlgHo^4?%t#M4nF`'P>3jQeNGUnMN>lb_O:H:QBj`\NS/g-6ESqoWa_ft*[.*IWh<>`XF*O>2.ahQm?8cM/E\Wk7o7H/'VCUP;WkPqhg0!q7&pRKr(]OIPF<;4OC!.fWSSYQ)"R$_mpOql9N.L+$\BYP0-E6s9/X'<%;F%Hn")I#@iI(%NJqH3X);oR;CDXoQ(".J+Q=EjJ<bj^Kp@:R,`::A*)+Z"P!3JnjLXtW7n:SS:*Z*5s,eCU7Q2>[M=llrg$9;@i,NUJmM$&Ba2<ZtSaUPl('tfkC3^jo_>Oc/-lUu)3%@sS$f("RTM#p/!U8Sn1V4iJ#IgJ4ZifAlp!8?b<B]@rW(lB8JW6X4go:<gLG^`Z@?UNl@6H@&(2YP_uD="^X_5'IO7"b_V1,3ZtfJafN_Xkc_\\,S_e*SEm]t&mOg+eq_B`]K=S<Laf+dsp;,G#2S=Cb7m+u!S>,9VS!Jih?P"2Sk;"63N9HkUUn*OK%a,5&*W(]-X)98O%rm4>D01>Z@t/p_hQ]Dhkgh?g^^[tGA539(pjUoQA^c2buFf5\hJkI2ok^8eB8fZ0r2VnMK/hT1F>[V8]3auZb3jGja-D@8f>>10gZ5DSu:DhbD/lRN/`Sl-9E+ZY\VcoYgaH>[WNjYn4]nZ8%j$+`nBg+D0DI+L<8rM6PA`.d5pQ<,:KD_IUs4ZtN+qaDNC(=L6klM_RNY<FjXIOe%p3c0kSg#XE"gfUYNPm!%rAK>`74ERO9)>IiEn8>/`bsu,q)bWj"L!iY4&?KWK+ZmtoiPEi8%lNT1\(7!bUYXh`6#1<Y2pFI9&TVhGa+;>7nYe=I)T0KS4jK=l_<9M,-s7eM=#_=_7jA-=penN.)<]isn2Sn21$a/)XiL?3AqE+pMDdOj`1,AM`rjP(@4Kd`0@@F>W-h4amk!fJe@[_U*r!(6kX-!/o3pE_M\XAG6FJVg%S_-c-A>meh)-`?ka`l%F!Q_i2?6U?@S+G:W:UDshuR"\qcf`*h"&dE?4cWKKQRe;a/mr[*PL:EOrK(E2jcmKLb_<TkN3nI"qOSrFAY:C'UREX.eo"%pj??%>A5!$&O"Rs8n*.8jVsF#;n*rTn-I/%Oi;.OL0iV?d]^%4lc<r$Q-Ij[h+7'.L*oeaYrH.1:Da>,jFN>78ETDS`4]M`]7t#V4`1Oa[nsre/LH<tJKS3ZKOjPk!B<()?&Vt#Y,m@@0&U!1Lk!jGq4_1$aDpd7T"sE2`@c[;\ad[tBVp&c\/#Hlp1Ml;LAO#']5A#:(u=cOqk3FRBlCY$Uf_Au)IkAk\'RG7L:;cW=*IBn7_fi&kIAUkjGNQB+IG>&hfp(9c;ERLijcBh(5S9ESjk.YBCA?V"Nf"uP!sK((6s6Dr()AdMWS$Cr%W,'f7k+4jHUuN)tAO4+QGKEQlR.f0[_TG>ru&mQ:mT&(\6r+(s.&1$qc*'NK'Id%AtP9Ii7JDQ481cpK"Mpd'RjGUq'W'0F/#)1;F)V*:QKASd.U2/<f%AKk96EWp'&lHZ:T<EML?%S,'?$lq723<U`Wj^Ge<U4^Mu?pYf_gg4Z*PIq$qOGd$N%8fQN,OsVu%!tBgkDI8W]a<V1U%o7%\9p8n%&"23f-J7,L?<aRAh7%?NA#[KR2<O`gMjM:&%pnMfmdB2'=Lko"LuadL2[+6g!U($r3Ffkt)A[Y4^8LLacVq3*nk0k54ls^Kfd$pDXoS[eEiO)-@K8U"JU)*TDt&MOkH_aNgM=go<0l@fKO8I)]I=^K["FM0k\5NRL`V\"j"3%AW[rAC:2QHeXjYWdR3>M9]-@<nO?`qZp'-]?a#X[B3_[QU=,U,5Cue67$H\B#k84F+meuThjgCXs/+4@pB.OkME*hdS[?BCgf&le;\*hIkG=IHJ^>,D$ZG[0/`R#N-h['-;(=lR8$Tn"t%(;>dM\3O`:>B^0J\.gdGW9)T'7<0q'1(1A38i:,[&f1T7^J4)6aq*%68GQ24,s:]EE^'mf*@,E4(kMf;T0od,>,7GaUm<*1"mTKbKgSP&#l]J:t'@E^\G"@_X+DlKM-(:6fR$^<`0Lh%!Q^2H*4cp3fFuDJb4/qo6/)e$nPqGUWY3')]O=K#9tIPK?k54bh^qkc])u01?pp3=?_H4df__.`(DBJp20n9A*)_QO(r<Yr+.,lGDT[/e0VcUoW:sD=^SK1O#iT\WK\JdA?R+s\u!0gi7<?8[(;QZDfitF6lp3qM38B/9tp^s9((D]I7L\[Gj]gh1Z6oO_b7FB,eA[T.;0ue`\RF[E=`s50p0Kb60B(-)@+:Y=L?Xi0j]d/*EB9/`OdtL(hIZ]+G)\-J^fc3M")RDiUI/.4;"\1\?tibb6GIZA!SOYCq0PU!_!4o\7BU1N?!e&>N7+`QW1M47nA35k.?41dsg^]>NS`r(>oTL-glpnG\!.Apj_f(3t!#'rrBCu>6/bFdSJ]p6'aid?A_2[FO(iG2urSV+3$?2ZR2Ra00Qt:@395WfH/kD;@>":i"2[cEcK&gDrY[Uip+AbCPWd(rrA)tkI5-b\N%kLLu=EB2@8c>j1ImUlC,`'j3(('H^LVBdOh2F@gai/3q"X=\H,8FJt@55Z)I>2J`C)GG[F+mA"#PahYu)!W'%Lk2"*"kp6-V8a!#M`ghk:A)6r/TQu"r/HpO4`j3+j=2K$htKWJnK(LrVQ)(^7UkcHsQVHrJ1\pFgcC%!9%g&7f(UDGBa:;TLt3@]"#k8!0/-LgH.XLH.&CC;YHP4S#NC=5MkQNAF1lAS1Lr2"Z+7XEY*ZZ-M9hngU1NJ5WCWt"ae8JtR78Ac7(?9Uk,$5E0u3!=d73igREB_F/f>Y?l\St@ZuH$'g4j+:'nj_Ss.gpu,E>k<mmX`^[hHLJf/*D;dfrrBGQ1VT@@gW^KfN$KZ&"7CfZF3#JE%<8?^W4)5^MW\-LZIJP==n_'G2\#on',?Zf.>G[l_(#^<3Pa=t!bsnSpjIXf_`c;5!5.,ME4JN(_6H@tI&B)8Y]:$7-jFdg`L;.t&L4o4>3kNjEgH'$1N1oIG@2@7EPgdE&pUMH%s[6o?h#2<V8m.q!4.nW)p;kLmlP_JAh1;RfF1&/Hf/q`L7R<CH$h3C>n_@\&%D=Wng8JddX:Z+#i-DN9UilN:-%O9?c%"/@ebf?%6eGQ'AQm4EuFP<B9Zg)53ubs"Ei":E,Zp_!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!keEN[o2Kt0(>ckbc`%AX!I8n#g!9QU.sKA5M^3EHWQll+lc?.?f1,e-]#-0MG7;DRGL#N?XheYlaB@YA*%/\1#O+[])e\1GXG!Q]KUFoCou]S1rZL@5^ep<h.-U)_#o7IoK4%Ho>LAYC>+E1TkTF`h.`gKGU9lj'ha/%)BGrja;N#*1,?Yq]7!m\]L>68YAE<?b?_JZ,5!<oKX\0+H=UY5SZpR#?OQYt`&I4#QPtmPXSGp'f$[(&)3IOs0Qp]Uc9WE[LXr(okWQX+=j*Z*3e`<VGBFD!FnS6tW_!W62Go^2]F'eH(V\ffWNA:2(q/rhe[3G7/pohbgq^4s]?u_QAQW>OJEV;#outJ7m:T"snCW@bP31_Gkr"GfaIXufn(os^m("5oN]?i/CKbG`eZXlnF/[4>f=A9=,IJ<79.U6a6ui$?KPrj+PE!Hslfge3I/a3*^Yj_=]YEFNNX]o+&5On7NtS73`o]9uD`m7F"8G4t>W+V'A#9RnMGe]id54W.lJH'\2VRQB(9ib#kal.m=D+N:3$tpn45jt75?bfr.aIo^nGUUaUY&krY)@>F_aL3QBE5L/5WK\,35QRmMC%b9K/B@^S!9C/eL]jnc-.9B8@N0*q=$j<]N:6rcQk)lYF$8CG:o<R)oicGeq3$tFLsP$42Q8r#s,?Ue#tkDLS\5&]P"38i6;?&lUm=g7oh?5!iq$7h9`]U,:*m),k+P66VW>,e`QDBMQUL<k(:cSe)IgF\TqX6=V\cqLFbH73:(rl4e8L/D7g\DI5L.(WGc27_5UVSG7m\jMM,OX3$)Dn]P[n`"9mkbhU[2-XE*1`qU$8.nH%S;cG-@6B[R:5%VLO]dQ,jBOJ.:XKFFgg3SG!M.b1_]kEEiMH;37Q4fW64O)\YaR97[0!pW_Z3+,3O3TgX)j(7`*]a'=?Fem[b=N$Z0JZN@5GS2^4)D45C!uO&cSt!=C5s9t1F5p%#l2sDb93ja8i[_K`T`*9#&Oumh>6RcAT"J[7H1kU/-2DicBXcn1&o,-*9k%s/a?UouVmfB`L02B@=((Gl"I"cW:JR17nTl-7-Lb9,O[ARK&DO"8<<RS[4+Y`IS.(Hnf'im7X(]uJp,DhX_[O,Yc/^fQ<%BFh^o#Hb3Q=Y3(uqbo+o$nkCDsV\!/8F\Uec1UT<#eXE?\$_!/OB8%cEZ9diS0c?9^*i,M)j+5DT6^4tL$tpeiCZ(gSq7r0D>bCG!u>a-V@bS1`T^c[P#f*Ab`W?>>oC(KrUug?[,-2OuP3hW,l!`2U*H-$^>>Y+&9Inn<5[:0!3LCM,QbC_2cs4*P0Z!O86(jq\jN^\tFqh.C"&>`D(hVG0tJip%;JBc[nVbAScN%)d_I7RF"<B'a*N]M#:"K>Cn,<r0_UMTfG]7RW-N0UD%qS8q1IRlrrOB8Y(*[u2WAO2;eUerMXGg6S+Xde(\[FHOEXK-98A;34AkoG'Z6?%1Bopjo3;LHNh^gtl:>>U8flOA-@^O.!fe&4sqC!-oplfM*`!(Olr8k]^6QGZesGSHnS>K?F2oSt@r(nX_o=UqRCeRb+,kROpT#!*QSST(bY%jH2'4(>paF,<1hFN/Tfs$jeK"FPn2r:Jea5e@m2Q)ZJ/^/[`iWoW^qOM&@K[r^O6$XV8Vk%tjQD#E:''aQ73)o\7IJN'u&fP!%RG(_pY"g`ALh]r4%HW9G?Gn4gU0K_JZ!O/L6:F*Nj;TJVOaSZLeTPU,0.UD]sGhtk\t?,*L=HKX8oO%,>OG5=S]phhN`,eT.Wk7q&HAQZD=d=MljJ\WXN.p?j)XSUF-7Ze*\QZ?2f6ZeM/U@MHqW=0Mu,j,7M#:+;\2bDAD7ATi>e3"#j6dI2SM`Y31ArK#$;\m<To5@O=c<"^E.)p>H\%6/=Q/YFEI1&fa]6u>%L;lm"52tBEgUQ6'(4VF)+CU=uDES"<#H;nH!9,<+h[f1g7jj%p-*`$>9a09<"HV\jA7.3T'u1&)SqI2MpYI1*9m5PfdkpjgDJ^uRk2@BF6H'qK;&J#2\&`WRW\V=J4E8(Xd][dhKpn'VZsO5K>$hMjMb3=[@RElP)%<*F;j+>UGA">i26#U6'R55h8S7J3U\=I7_eIi$Ku?ha$^Erg/`m*ga5&phodS]+=dErQ<NH]PBf\(s8J]e>cZ^KeW-3!M`XX[=EU1^oTZ94'H1U9L-+!,;L,E\HNi@"6OS1W=`@=?V3uH9:gd0R`Cm>.n_O^pW%6sV3$7MX!$rMm1TEN'*'N%+'MG+@*TE>n8;*Y=6`=u,M@Z4/Q!#VIF;*Y<h/JM"_?r;e0TE>m;MC8Rd[.&7FVTp@6r+2fmV=/X*1YTYrTXtt!Q'@l9rSY`Q]":$`Ci*),!(&;5=QH_7-&M%],a7#I72,bd.)cls!msFN!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!*0:'!/#B16WTORA@o:aR8kT*b4]U_PV3EZb@TL\`_SRgM?)/T[*)/ngW6a\Wg;H,m`tA]!8Pl<ZQ&s#8N6h#XjKQ;'N%:!'N%:!J,e1~>
endstream
endobj
21 0 obj
<<
/Encoding /WinAnsiEncoding
/Type /Font
/Name /F2
/BaseFont /Helvetica-Bold
/Subtype /Type1
>>
endobj
22 0 obj
<<
/Encoding /WinAnsiEncoding
/Type /Font
/Name /F3
/BaseFont /Times-Roman
/Subtype /Type1
>>
endobj
23 0 obj
<<
/Encoding /WinAnsiEncoding
/Type /Font
/Name /F1
/BaseFont /Helvetica
/Subtype /Type1
>>
endobj
24 0 obj
<<
/Encoding /SymbolEncoding
/Type /Font
/Name /F4
/BaseFont /Symbol
/Subtype /Type1
>>
endobj
xref
0 25
0000000000 65535 f 
0000000009 00000 n 
0000000086 00000 n 
0000000187 00000 n 
0000000236 00000 n 
0000000469 00000 n 
0000000767 00000 n 
0000001066 00000 n 
0000001376 00000 n 
0000021780 00000 n 
0000021892 00000 n 
0000022002 00000 n 
0000022110 00000 n 
0000029692 00000 n 
0000045038 00000 n 
0000054045 00000 n 
0000069391 00000 n 
0000069504 00000 n 
0000069614 00000 n 
0000069722 00000 n 
0000079931 00000 n 
0000095277 00000 n 
0000095390 00000 n 
0000095500 00000 n 
0000095608 00000 n 
trailer
<<
/Size 25
/Root 3 0 R
/Info 2 0 R
>>
startxref
95712
%%EOF
